In this section:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | Y | Z | 1 |A
- Alcohol, abstainers lifetime (%) (Global Information System on Alcohol and Health)
- Alcohol, abstainers past 12 months (%) (Global Information System on Alcohol and Health)
- Action Plan for implementation of alcohol policy (Global Information System on Alcohol and Health)
- Adolescent birth rate (per 1000 women aged 15-19 years) (Global strategy for women's, children's and adolescents' health)
- Adolescent birth rate (births per 1,000 women aged 15 to 19) (Urban health)
- Adolescent mortality rate (per 100 000 population) (Global strategy for women's, children's and adolescents' health)
- Adopted written national policy on alcohol (Global Information System on Alcohol and Health)
- Adult mortality rate (probability of dying between 15 and 60 years per 1000 population) (Mortality and global health estimates)
- Advertising restrictions at cinemas (Global Information System on Alcohol and Health)
- Advertising restrictions at point-of-sale (Global Information System on Alcohol and Health)
- Advertising restrictions in print media (Global Information System on Alcohol and Health)
- Advertising restrictions on billboards (Global Information System on Alcohol and Health)
- Advertising restrictions on cable television (Global Information System on Alcohol and Health)
- Advertising restrictions on local radio (Global Information System on Alcohol and Health)
- Advertising restrictions on national radio (Global Information System on Alcohol and Health)
- Advertising restrictions on national television (Global Information System on Alcohol and Health)
- Advertising restrictions on social media (Global Information System on Alcohol and Health)
- Advertising restrictions on the internet (Global Information System on Alcohol and Health)
- Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI (Global Information System on Alcohol and Health)
- Age-standardized DALYs, alcohol and drug use disorders, per 100 000 (Resources for Substance Use Disorders)
- Age-standardized death rates, alcohol and drug use disorders, per 100 000 (Resources for Substance Use Disorders)
- Alcohol consumption among adults aged ≥ 15 years (litres of pure alcohol per person per year) (Noncommunicable diseases)
- Alcohol, consumers past 12 months (%) (Global Information System on Alcohol and Health)
- Alcohol content displayed on containers (Global Information System on Alcohol and Health)
- Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI (Global Information System on Alcohol and Health)
- Alcohol expenditure as a per cent of total household expenditure (Global Information System on Alcohol and Health)
- Age limits on-premise service (Global Information System on Alcohol and Health)
- Age limits off-premise sales (Global Information System on Alcohol and Health)
- Alcohol use disorders (15+), 12 month prevalence (%) with 95% (Global Information System on Alcohol and Health)
- Alcohol use is banned (Global Information System on Alcohol and Health)
- Alcohol-attributable fractions (15+), liver cirrhosis deaths (%) (Global Information System on Alcohol and Health)
- Alcohol-attributable fractions (15+), road traffic crash deaths (%) (Global Information System on Alcohol and Health)
- Alcohol-attributable fractions, all-cause deaths (%) (Global Information System on Alcohol and Health)
- Alcohol-related crimes (% of all crimes) (Global Information System on Alcohol and Health)
- Alcohol-related road traffic crashes (% of all traffic crashes) (Global Information System on Alcohol and Health)
- Alcohol-related road traffic crashes, per 100,000 population (Global Information System on Alcohol and Health)
- Alcoholic beverage legally defined (Global Information System on Alcohol and Health)
- Alcoholic excise tax revenue as a per cent of government revenue (Global Information System on Alcohol and Health)
- Annual revenues from alcohol excise tax in millions US$ (Global Information System on Alcohol and Health)
- Antenatal care attendees positive for syphilis who received treatment (%) (Sexually Transmitted Infections)
- Antenatal care attendees who were positive for syphilis (%) (Sexually Transmitted Infections)
- Antenatal care coverage - at least four visits (%) (Global strategy for women's, children's and adolescents' health)
- Availability of generic anti-dementia medication (Global Dementia Observatory (GDO))
- Availability of at least one anti-dementia medication approved for on-label use reimbursement (Global Dementia Observatory (GDO))
- Availability of atleast one adult hygiene products for people with dementia (Global Dementia Observatory (GDO))
- Availability of atleast one assistive technology for people with dementia (Global Dementia Observatory (GDO))
- Availability of atleast one housing adjustment for people with dementia (Global Dementia Observatory (GDO))
- At least one national mass media campaign ran during the survey period (Noncommunicable diseases)
- Alcohol, average daily intake in grams among drinkers with 95%CI (Global Information System on Alcohol and Health)
- Awareness activities (Global Information System on Alcohol and Health)
- Appearance of tobacco products in TV and/or films (Noncommunicable diseases)
- Age-standardized DALYs attributable to the environment (per 100 000 population) (Public health and environment)
- Availability of estimates on large health expenditures as a share of total expenditure or income (Universal health coverage)
- Average - cigarette currency (Noncommunicable diseases)
- Average - cigarette price in currency (Noncommunicable diseases)
- Average - cigarette price in international dollars (Noncommunicable diseases)
- Average - cigarette price in US$ at official exchange rates (Noncommunicable diseases)
- Average - taxes as a % of cigarette price - specific excise (Noncommunicable diseases)
- Average - taxes as a % of cigarette price - ad valorem excise (Noncommunicable diseases)
- Average - taxes as a % of cigarette price - import duties (Noncommunicable diseases)
- Average - taxes as a % of cigarette price - value added tax (Noncommunicable diseases)
- Average - taxes as a % of cigarette price - other taxes (Noncommunicable diseases)
- Average - taxes as a % of cigarette price - total tax (Noncommunicable diseases)
- Availability of activities of daily living suppport services in community for dementia (Global Dementia Observatory (GDO))
- Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Availability of behaviour and psychological management in community for dementia (Global Dementia Observatory (GDO))
- Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Availability of diagnostic services in community for dementia (Global Dementia Observatory (GDO))
- Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Availability of palliative and end-of-life care services in community for dementia (Global Dementia Observatory (GDO))
- Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Availability of psychosocial and rehabilitation services in community for dementia (Global Dementia Observatory (GDO))
- Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Availability of social and financial protection for dementia (Global Dementia Observatory (GDO))
- Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Average of 13 International Health Regulations core capacity scores (Universal health coverage)
- Alcohol, consumption of pure alcohol by type of beverage (%) (Global Information System on Alcohol and Health)
- Ambient air pollution attributable DALYs (per 100 000) (Public health and environment)
- Ambient air pollution attributable DALYs (per 100 000, age-standardized) (Public health and environment)
- Ambient air pollution attributable DALYs (Public health and environment)
- Age-standardized deaths attributable to the environment (per 100 000 population) (Public health and environment)
- Ambient air pollution attributable deaths (per 100 000) (Public health and environment)
- Ambient air pollution attributable deaths (per 100 000, age-standardized) (Public health and environment)
- Ambient air pollution attributable deaths (Public health and environment)
- Availability of mechanisms to coordinate dementia care across sectors (Global Dementia Observatory (GDO))
- Availability of dementia care coordination standards/ guidelines/ protocols (Global Dementia Observatory (GDO))
- Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] (Global Dementia Observatory (GDO))
- Adult day centres (Global Dementia Observatory (GDO))
- Adult day centre places (per 10,000 population) (Global Dementia Observatory (GDO))
- Availability of routine hospital admissions records for people with dementia for monitoring purposes (Global Dementia Observatory (GDO))
- Availability of routine outpatient visit records for people with dementia for monitoring purposes (Global Dementia Observatory (GDO))
- Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes (Global Dementia Observatory (GDO))
- Availability of routine pharmaceutical records for people with dementia for monitoring purposes (Global Dementia Observatory (GDO))
- Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes (Global Dementia Observatory (GDO))
- Availability and status of dementia reporting in the past two years (Global Dementia Observatory (GDO))
- Availability of funding for dementia national plan (Global Dementia Observatory (GDO))
- Availability of funding for dementia-specific research plan/programme (Global Dementia Observatory (GDO))
- Availability of investigational pharmaceutical trials for dementia (Global Dementia Observatory (GDO))
- Availability of dementia-friendly initiatives that improve accessibility (Global Dementia Observatory (GDO))
- Availability of dementia diagnostic rate (Global Dementia Observatory (GDO))
- Attribution of road traffic deaths to alcohol (%) (Road Safety)
- Alcohol, drinkers only (recorded 3 year average + unrecorded) per capita (15+)consumption in litres of pure alcohol (Global Information System on Alcohol and Health)
- Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (% (Health Equity Monitor)
- Antenatal care coverage - at least one visit (in the five years preceding the survey) (%) (Health Equity Monitor)
- Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%) (Health Equity Monitor)
- Antenatal care coverage - at least four visits (in the five years preceding the survey) (%) (Health Equity Monitor)
- Adolescent fertility rate (per 1000 women aged 15-19 years) (Health Equity Monitor)
- Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010 (Global Information System on Alcohol and Health)
- Alcohol-related road traffic crashes with fatalities, per 100,000 population (Global Information System on Alcohol and Health)
- Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities) (Global Information System on Alcohol and Health)
- Alcohol, former drinkers (%) (Global Information System on Alcohol and Health)
- Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI (Global Information System on Alcohol and Health)
- Are the health warnings on cigarette packaging rotating? (Noncommunicable diseases)
- Are the health warnings on cigarette packaging written in the principal language(s) of the country? (Noncommunicable diseases)
- Are the health warnings on other smoked tobacco packaging rotating? (Noncommunicable diseases)
- Are the health warnings on other smoked tobacco packaging written in the principal language(s) of the country? (Noncommunicable diseases)
- Are the health warnings on smokeless tobacco packaging rotating? (Noncommunicable diseases)
- Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country? (Noncommunicable diseases)
- Alcohol, heavy episodic drinking (population) past 30 days (%) (Global Information System on Alcohol and Health)
- Alcohol, heavy episodic drinking (drinkers only) past 30 days (%) (Global Information System on Alcohol and Health)
- Availability of national standards or recommended lists of medical devices (Priority health technologies)
- Age-standardized mortality rate attributed to household and ambient air pollution (per 100 000 population) (Global strategy for women's, children's and adolescents' health)
- Applicability of national motorcycle helmet law to all road types (Road Safety)
- Applicability of national motorcycle helmet law to all engine types (Road Safety)
- Applicability of national motorcycle helmet law to all occupants (Road Safety)
- Availability of cardiovascular risk stratification in 50% or more primary health care facilities (Noncommunicable diseases)
- Access restrictions (Public health and environment)
- Annual budget for tobacco control in currency reported (Noncommunicable diseases)
- Alcohol, patterns of drinking score (Global Information System on Alcohol and Health)
- Annual population growth rate (%) (Demographic and socioeconomic statistics)
- Availability of estimates on impoverishment due to out-of-pocket health expenditures (Universal health coverage)
- Adult survey age range - smokeless (Noncommunicable diseases)
- Adult smokeless tobacco use indicator definition (Noncommunicable diseases)
- Adult smokeless tobacco use indicator rate (Noncommunicable diseases)
- Adult survey age range (Noncommunicable diseases)
- Adult indicator 1 definition (Noncommunicable diseases)
- Adult indicator 1 rate (Noncommunicable diseases)
- Adult indicator 2 definition (Noncommunicable diseases)
- Adult indicator 2 rate (Noncommunicable diseases)
- Age-standardized prevalence of current tobacco smoking among persons aged 15 years and older (Global strategy for women's, children's and adolescents' health)
- Availability of national list of approved medical devices for procurement or reimbursement (Priority health technologies)
- Availability of technical specifications of medical devices to support procurement or donations (Priority health technologies)
- All other indoor public places (national legislation) (Noncommunicable diseases)
- Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol) (Global Information System on Alcohol and Health)
- Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average (Global Information System on Alcohol and Health)
- Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI (Global Information System on Alcohol and Health)
- Alcohol, regional per capita (15+) consumption (in litres of pure alcohol) (Global Information System on Alcohol and Health)
- Alcohol, regional prevalence of alcohol dependence (%) (Global Information System on Alcohol and Health)
- Alcohol, regional prevalence of alcohol use disorders (%) (Global Information System on Alcohol and Health)
- Alcohol, heavy episodic drinking (population) past 30 days (%), age-standardized with 95%CI (Global Dementia Observatory (GDO))
- Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025 (Global Dementia Observatory (GDO))
- Applicability of seat-belt law to all occupants (Road Safety)
- Adaptation of national speed limit at a local level (Road Safety)
- Anti-tobacco mass media campaigns (Noncommunicable diseases)
- Availability of funding for national road safety strategy (Road Safety)
- Age-standardized suicide rates (per 100 000 population) (Mental health)
- Affordability: % of GDP per capita required to purchase 100 packs of most sold brand (the higher the %, the less affordable) (Noncommunicable diseases)
- Affordability: Cigarettes are less affordable in 2014 compared to 2008 (Noncommunicable diseases)
- Affordability: Specific tax component automatically adjusted for inflation (or other) (Noncommunicable diseases)
- Affordability: Price dispersion: share of cheapest brand price in premium brand price (the higher the % the smaller the gap) (Noncommunicable diseases)
- Annual tax revenues - tobacco products included (Noncommunicable diseases)
- Annual tax revenues - year (Noncommunicable diseases)
- Annual tax revenues - currency (Noncommunicable diseases)
- Annual tax revenues - total excise (specific and ad valorem) (Noncommunicable diseases)
- Annual tax revenues - value added tax (vat) and other sales taxes (Noncommunicable diseases)
- Annual tax revenues - import duties and all other taxes (excluding corporate taxes on tobacco companies) (Noncommunicable diseases)
- Annual tax revenues - total revenues (Noncommunicable diseases)
- Age-standardized mortality rate by cause (per 100 000 population) (Noncommunicable diseases)
- Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) (Global Information System on Alcohol and Health)
- Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI (Global Information System on Alcohol and Health)
- Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016 (Global Information System on Alcohol and Health)
- Alcohol, tourist consumption (in litres of pure alcohol) (Global Information System on Alcohol and Health)
- Access to a toll-free quit line (Noncommunicable diseases)
- Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) (Global Information System on Alcohol and Health)
- Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI (Global Information System on Alcohol and Health)
- Adopted written national policy on alcohol, year adopted (Global Information System on Alcohol and Health)
- Adopted written national policy on alcohol, year revised (Global Information System on Alcohol and Health)
- Alcohol-attributable Years of Life Lost (YLL) score (Global Information System on Alcohol and Health)
- Ambient air pollution attributable YLLs (Public health and environment)
B
- Ban on tobacco vending machines (Noncommunicable diseases)
- Ban on internet sales of tobacco products (Noncommunicable diseases)
- Ban on display of tobacco products at points of sale (Noncommunicable diseases)
- Ban on deceitful terms on cigarette packaging (Noncommunicable diseases)
- Ban on deceitful terms on other smoked tobacco packaging (Noncommunicable diseases)
- Ban on deceitful terms on smokeless tobacco packaging (Noncommunicable diseases)
- Blood Alcohol Concentration (BAC) limit for drivers (Road Safety)
- Billboard and outdoor advertising (Noncommunicable diseases)
- Brand name of non-tobacco products used for tobacco product (Noncommunicable diseases)
- Ban on appearance of tobacco brands in TV and/or films (product placement) (Noncommunicable diseases)
- Beds for mental health in general hospitals (per 100,000) (Mental health)
- Beds in community residential facilities (per 100,000) (Mental health)
- Beds in mental hospitals (per 100,000) (Mental health)
- Beds for the treatment of substance use disorders, per 100 000 (Resources for Substance Use Disorders)
- Biomedical engineers density (per 10 000 population) (Health workforce)
- Births attended by skilled health personnel (%) (Global strategy for women's, children's and adolescents' health)
- Births by caesarean section (%) (Maternal and reproductive health)
- Budget line for substance use disorder prevention (Resources for Substance Use Disorders)
- Budget line for substance use disorder treatment (Resources for Substance Use Disorders)
- Buprenorphine provision in clinical and community-based settings (Resources for Substance Use Disorders)
- Buprenorphine used for the treatment of opioid dependence (Resources for Substance Use Disorders)
- Buprenorphine used for detoxification or maintenance (Resources for Substance Use Disorders)
- Buprenorphine/naloxone provision in clinical and community-based settings (Resources for Substance Use Disorders)
- Buprenorphine/naloxone used for detoxification or maintenance (Resources for Substance Use Disorders)
- Births attended by skilled health personnel (in the two or three years preceding the survey) (%) (Health Equity Monitor)
- Births attended by skilled health personnel (in the five years preceding the survey) (%) (Health Equity Monitor)
- Births by caesarean section (in the two or three years preceding the survey) (%) (Health Equity Monitor)
- Births by caesarean section (in the five years preceding the survey) (%) (Health Equity Monitor)
- BCG immunization coverage among one-year-olds (%) (Health Equity Monitor)
- BCG immunization coverage among 1-year-olds (%) (Universal health coverage)
- Bupropion - legally sold (Noncommunicable diseases)
- Bupropion - place available (Noncommunicable diseases)
- Bupropion - cost covered (Noncommunicable diseases)
- Budget year (Noncommunicable diseases)
C
- Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors (Noncommunicable diseases)
- Cigarette packaging and labelling must not use descriptors depicting flavours (Noncommunicable diseases)
- Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark (Noncommunicable diseases)
- Cigarette packaging and labelling must display qualitative information on relevant constituents and emissions (Noncommunicable diseases)
- Cigarette packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas (Noncommunicable diseases)
- Cigarette packaging and labelling must not display expiry dates (Noncommunicable diseases)
- Contraceptive prevalence - modern methods (%) (Health Equity Monitor)
- Contraceptive prevalence - modern and traditional methods (%) (Health Equity Monitor)
- Coordination (International Health Regulations (2005) monitoring framework)
- Chemical (International Health Regulations (2005) monitoring framework)
- Coverage of antenatal care (4 visits) (Urban health)
- Campaign was part of a comprehensive tobacco control programme (Noncommunicable diseases)
- Campaign was pre-tested (Noncommunicable diseases)
- Campaign aired on television and/or radio (Noncommunicable diseases)
- Campaign utilized media planning (Noncommunicable diseases)
- Civil registration coverage of births (%) (Global strategy for women's, children's and adolescents' health)
- Clinical guidelines for brief interventions (Global Information System on Alcohol and Health)
- Climate change attributable deaths (Public health and environment)
- Climate change attributable DALYs ('000) (Public health and environment)
- Climate change attributable deaths per 100'000 capita (Public health and environment)
- Climate change attributable DALYs per 100'000 capita (Public health and environment)
- Climate change attributable deaths ('000) in children under 5 years (Public health and environment)
- Climate change attributable deaths per 100'000 children under 5 years (Public health and environment)
- Climate change attributable DALYs ('000) in children under 5 years (Public health and environment)
- Climate change attributable DALYs per 100'000 children under 5 years (Public health and environment)
- Cautions and arrests for drink-driving, per 100,000 population (Global Information System on Alcohol and Health)
- Cautions and arrests for public drunkenness, per 100,000 population (Global Information System on Alcohol and Health)
- Central coordinating entity for alcohol policy implementation (Global Information System on Alcohol and Health)
- Coverage of national cervical cancer screening program (%) (Universal health coverage)
- Citizen complaints and investigations (Noncommunicable diseases)
- Comprehensive bans in place subnationally (Noncommunicable diseases)
- Children aged <5 years overweight <br> (% weight-for-height >+2 SD) (Child malnutrition)
- Children aged <5 years stunted <br> (% height-for-age <-2 SD) (Child malnutrition)
- Children aged <5 years underweight <br> (% weight-for-age <-2 SD) (%) (Child malnutrition)
- Children aged <5 years wasted <br> (% weight-for-height <-2 SD) (Child malnutrition)
- Children under five who slept under an ITN the previous night (%) (Urban health)
- Children under five who slept under a bednet the previous night (%) (Urban health)
- Children aged 36-59 months who are developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning (%) (Global strategy for women's, children's and adolescents' health)
- Cheapest brand of cigarettes - currency reported (Noncommunicable diseases)
- Cheapest brand of cigarettes - price in currency reported (Noncommunicable diseases)
- Cheapest brand of cigarettes - price in international dollars (Noncommunicable diseases)
- Cheapest brand of cigarettes - price in US$ at official exchange rates (Noncommunicable diseases)
- Clinical supervision of health care staff (Resources for Substance Use Disorders)
- Commencement of treatment with opioid agonists (Resources for Substance Use Disorders)
- Commitments to recipient countries (Million, constant 2009 US$) (Governance and aid effectiveness)
- Compliance with bans on direct advertising (Noncommunicable diseases)
- Compliance of ban on advertising on national TV and radio (Noncommunicable diseases)
- Compliance of ban on advertising on local magazines and newspapers (Noncommunicable diseases)
- Compliance of ban on advertising on billboards and outdoor advertising (Noncommunicable diseases)
- Compliance of ban on advertising at point of sale (Noncommunicable diseases)
- Compliance with bans on promotion and sponsorship (Noncommunicable diseases)
- Compliance of ban on free distribution of tobacco products in the mail or through other means (Noncommunicable diseases)
- Compliance of ban on promotional discounts (Noncommunicable diseases)
- Compliance of ban on non-tobacco goods AND services identified with tobacco brand names (Noncommunicable diseases)
- Compliance of ban on brand name of non-tobacco products used for tobacco product (Noncommunicable diseases)
- Compliance of ban on appearance of tobacco brands in TV and/or films (product placement) (Noncommunicable diseases)
- Compliance of ban on appearance of tobacco products in TV and/or films (Noncommunicable diseases)
- Compliance of ban on sponsored events (Noncommunicable diseases)
- Compliance with regulations on smoke-free environments (national legislation) (Noncommunicable diseases)
- Compliance of ban on smoking in HEALTH-CARE FACILITIES (Noncommunicable diseases)
- Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES (Noncommunicable diseases)
- Compliance of ban on smoking in UNIVERSITIES (Noncommunicable diseases)
- Compliance of ban on smoking in GOVERNMENT FACILITIES (Noncommunicable diseases)
- Compliance of ban on smoking in INDOOR OFFICES (Noncommunicable diseases)
- Compliance of ban on smoking in RESTAURANTS (Noncommunicable diseases)
- Compliance of ban on smoking in PUBS AND BARS (Noncommunicable diseases)
- Compliance of ban on smoking in PUBLIC TRANSPORT (Noncommunicable diseases)
- Confidentiality of health records on substance use disorders protected by law (Resources for Substance Use Disorders)
- Congenital Rubella Syndrome - number of reported cases (Vaccine-preventable communicable diseases)
- Congenital syphilis number of reported cases (Sexually Transmitted Infections)
- Congenital syphilis rate per 100 000 live births (Sexually Transmitted Infections)
- Consumer information about calories, additives, etc on containers (Global Information System on Alcohol and Health)
- Contraceptive prevalence rate among women married or in union (Urban health)
- Crude birth rate (per 1000 population) (Demographic and socioeconomic statistics)
- Crude death rate (per 1000 population) (Demographic and socioeconomic statistics)
- Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%) (Health financing)
- Current health expenditure (CHE) per capita in PPP int$ (Health financing)
- Current health expenditure (CHE) per capita in US$ (Health financing)
- Coverage of DTP3 immunization (Urban health)
- Civil registration coverage of cause-of-death (%) (Health systems)
- Care facilities [hospice centres] (Global Dementia Observatory (GDO))
- Care facilities [long-term care] (Global Dementia Observatory (GDO))
- Community and traditional health workers density (per 1000 population) (Health workforce)
- Confirmed cases of RR-/MDR-TB (Tuberculosis)
- Cases started on MDR-TB treatment (Tuberculosis)
- Children aged 6-59 months who received vitamin A supplementation (%) (Health Equity Monitor)
- Children aged < 5 years sleeping under insecticide-treated nets (%) (Health Equity Monitor)
- Children aged < 5 years with diarrhoea receiving oral rehydration salts (%) (Health Equity Monitor)
- Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%) (Health Equity Monitor)
- Children aged < 5 years with pneumonia symptoms taken to a health facility (%) (Health Equity Monitor)
- Composite coverage index (%) (Health Equity Monitor)
- Concentrations of fine particulate matter (PM2.5) (Public health and environment)
- Community residential facilities (per 100,000) (Mental health)
- Cholera case fatality rate (Cholera)
- Community-based interventions involving stakeholders (Global Information System on Alcohol and Health)
- Coverage of measles immunization (Urban health)
- Current smoking of any tobacco product (age-standardized rate) (Noncommunicable diseases)
- Current smoking of cigarettes (age-standardized rate) (Noncommunicable diseases)
- Children aged 6-59 months who received vitamin A supplementation (%) (Child health)
- Children aged < 5 years with pneumonia symptoms taken to a healthcare provider (%) (Child health)
- Children aged <5 years with ARI symptoms who took antibiotic treatment (%) (Child health)
- Children aged <5 years with diarrhoea receiving ORS (%) (Child health)
- Children aged <5 years sleeping under insecticide-treated nets (%) (Child health)
- Children aged <5 years with fever who received treatment with any antimalarial (%) (Child health)
- Child maltreatment: Extent of implementation of home-visiting programmes (Violence prevention)
- Comprehensive and regular reporting of alcohol situation (Global Information System on Alcohol and Health)
- Coverage of skilled birth attendance (Urban health)
- Crude suicide rates (per 100 000 population) (Global strategy for women's, children's and adolescents' health)
D
- Demand for family planning satisfied - modern and traditional methods (%) (Health Equity Monitor)
- Demand for family planning satisfied - modern methods (%) (Health Equity Monitor)
- Data on substance use disorders disseminated in national annual reports (Resources for Substance Use Disorders)
- Deaths, children aged under 5 years (Public health and environment)
- Disability-adjusted life years (DALYs), children aged under 5 years (000s) (Public health and environment)
- Deaths total (Public health and environment)
- Disability-adjusted life years (DALYs) total (000s) (Public health and environment)
- Deaths per 100 000 population (Public health and environment)
- Disability-adjusted life years (DALYs) per 100 000 population (Public health and environment)
- Disability-adjusted life years (DALYs) attributable to the environment (Public health and environment)
- Disability-adjusted life years (DALYs) attributable to the environment (%) (Public health and environment)
- Dedicated funds for enforcement (Noncommunicable diseases)
- Disbursements to recipient countries (Million, constant 2009 US$) (Governance and aid effectiveness)
- Deaths attributable to the environment (Public health and environment)
- Deaths attributable to the environment (%) (Public health and environment)
- Density of adult day centres (per 100,000 population) (Global Dementia Observatory (GDO))
- Dementia-specific adult day centre places (per 10,000 population) (Global Dementia Observatory (GDO))
- Density of hospice centres (per 100,000 population) (Global Dementia Observatory (GDO))
- Dementia-specific hospice care beds (per 10,000 population) (Global Dementia Observatory (GDO))
- Dementia care facilities [hospitals] (Global Dementia Observatory (GDO))
- Dementia-specific hospital beds (per 10,000 population) (Global Dementia Observatory (GDO))
- Density of residential long-term care facilities (per 100,000 population) (Global Dementia Observatory (GDO))
- Dementia-specific residential long-term care beds (per 10,000 population) (Global Dementia Observatory (GDO))
- Density of outpatient health centres (per 100,000 population) (Global Dementia Observatory (GDO))
- Density of outpatient social centres (per 100,000 population) (Global Dementia Observatory (GDO))
- Dementia integrated into other national plan (Global Dementia Observatory (GDO))
- Dementia integrated into other national research plan/programme (Global Dementia Observatory (GDO))
- Dementia nongovernmental organization equipped with office (Global Dementia Observatory (GDO))
- Dementia nongovernmental organization office branches (Sub-national) (Global Dementia Observatory (GDO))
- Dementia nongovernmental organization office branches (Local) (Global Dementia Observatory (GDO))
- Dementia nongovernmental organization office branches (National only) (Global Dementia Observatory (GDO))
- Dementia nongovernmental organization staff primarily salaried/volunteer (Global Dementia Observatory (GDO))
- Dementia nongovernmental organization's involvement in policy development (Global Dementia Observatory (GDO))
- Dentistry personnel density (per 1000 population) (Health workforce)
- Detection of marketing infringements (Global Information System on Alcohol and Health)
- Diphtheria - number of reported cases (Vaccine-preventable communicable diseases)
- Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%) (Health financing)
- Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%) (Health financing)
- Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%) (Health financing)
- Domestic general government health expenditure (GGHE-D) per capita in PPP int$ (Health financing)
- Domestic general government health expenditure (GGHE-D) per capita in US$ (Health financing)
- Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%) (Health financing)
- Domestic private health expenditure (PVT-D) per capita in PPP int$ (Health financing)
- Domestic private health expenditure (PVT-D) per capita in US$ (Health financing)
- Donor commitments (Million, constant 2009 US$) (Governance and aid effectiveness)
- Donor disbursements (Million, constant 2009 US$) (Governance and aid effectiveness)
- Definition of drink-driving by BAC (Road Safety)
- Drug courts (Resources for Substance Use Disorders)
- Duty paid or excise stamp on alcohol container (Global Information System on Alcohol and Health)
- DTP3 immunization coverage among one-year-olds (%) (Health Equity Monitor)
- Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%) (Universal health coverage)
- Data collected on harm from alcohol at workplace (Global Information System on Alcohol and Health)
- Data collection on Foetal Alcohol Syndome (Global Information System on Alcohol and Health)
- Does the law mandate specific health warnings on cigarette packaging? (Noncommunicable diseases)
- Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale? (Noncommunicable diseases)
- Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health? (Noncommunicable diseases)
- Does the law mandate font style, font size and colour of health warnings on cigarette packaging? (Noncommunicable diseases)
- Do the health warnings on cigarette packaging include a photograph or graphic? (Noncommunicable diseases)
- Does the law mandate specific health warnings on other smoked tobacco packaging? (Noncommunicable diseases)
- Do health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale? (Noncommunicable diseases)
- Do health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health? (Noncommunicable diseases)
- Does the law mandate font style, font size and colour of health warnings on other smoked tobacco packaging? (Noncommunicable diseases)
- Do the health warnings on other smoked tobacco packaging include a photograph or graphic? (Noncommunicable diseases)
- Does the law mandate specific health warnings on smokeless tobacco packaging? (Noncommunicable diseases)
- Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale? (Noncommunicable diseases)
- Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health? (Noncommunicable diseases)
- Does the law mandate font style, font size and colour of health warnings on smokeless tobacco packaging? (Noncommunicable diseases)
- Do the health warnings on smokeless tobacco packaging include a photograph or graphic? (Noncommunicable diseases)
- Data availability for UHC index of essential service coverage (ranking) (Universal health coverage)
- Data availability for UHC index of essential service coverage (%) (Universal health coverage)
- Deaths due to tuberculosis among HIV-negative people (per 100 000 population) (Tuberculosis)
- Daily smoking of any tobacco product (age-standardized rate) (Noncommunicable diseases)
- Daily smoking of cigarettes (age-standardized rate) (Noncommunicable diseases)
- Distribution of road traffic deaths by type of road user (%) (Road Safety)
- Deaths per 1 000 live births (Mortality and global health estimates)
- Distribution of causes of death among children aged < 5 years (%) (Mortality and global health estimates)
E
- Existence of a national policy on walking and cycling (Road Safety)
- Existence of a national policy on public transport (Road Safety)
- Earned media/public relations were used to promote the campaign (Noncommunicable diseases)
- Existence of national screening program for cervical cancer (Universal health coverage)
- Existence of a national child-restraint law (Road Safety)
- Estimated number of people receiving activities of daily living support services in community for dementia (Global Dementia Observatory (GDO))
- Estimated number of people receiving behaviour and psychological management services in community for dementia (Global Dementia Observatory (GDO))
- Existence of community-based health or social care services for dementia (Global Dementia Observatory (GDO))
- Estimated number of people receiving palliative and end-of-life care services in community for dementia (Global Dementia Observatory (GDO))
- Estimated number of people receiving psychosocial and rehabilitation services in community for dementia (Global Dementia Observatory (GDO))
- Estimated number of people with dementia receiving social and financial protection for dementia (Global Dementia Observatory (GDO))
- Existence of a road safety lead agency (Road Safety)
- Existence of at least one functioning dementia awareness campaign (Global Dementia Observatory (GDO))
- Existence of at least one functioning risk reduction campaign (Global Dementia Observatory (GDO))
- Existence of dementia carer support services (Global Dementia Observatory (GDO))
- Existence of dedicated resources for dementia carer support services (Global Dementia Observatory (GDO))
- Existence of implementation plan for dementia carer support services (Global Dementia Observatory (GDO))
- Existence of dementia carer training and education (Global Dementia Observatory (GDO))
- Estimated number of dementia carers receiving training and education (Global Dementia Observatory (GDO))
- Existence of financial benefits/social protection for dementia carers (Global Dementia Observatory (GDO))
- Estimated number of dementia carers receiving financial benefits/social protection (Global Dementia Observatory (GDO))
- Existence of information on legal rights for dementia carers (Global Dementia Observatory (GDO))
- Estimated number of dementia carers receiving information on legal rights (Global Dementia Observatory (GDO))
- Existence of psycho-social supports for dementia carers (Global Dementia Observatory (GDO))
- Estimated number of dementia carers receiving psycho-social supports (Global Dementia Observatory (GDO))
- Existence of respite care for dementia carers (Global Dementia Observatory (GDO))
- Estimated number of dementia carers receiving respite care (Global Dementia Observatory (GDO))
- Existence of dementia training for volunteers (Global Dementia Observatory (GDO))
- Existence of dementia training for police and fire services (Global Dementia Observatory (GDO))
- Existence of dementia training for first responders (Global Dementia Observatory (GDO))
- Existence of dementia training for legal professionals (Global Dementia Observatory (GDO))
- Existence of dementia training for community workers (Global Dementia Observatory (GDO))
- Existence of dementia training for school children (Global Dementia Observatory (GDO))
- Existence of dementia training for financial service staff (Global Dementia Observatory (GDO))
- Existence of dementia training for retail and hospitality staff (Global Dementia Observatory (GDO))
- Existence of dementia representative in ministry (Global Dementia Observatory (GDO))
- Estimated percentage of hospitals following national dementia standards (Global Dementia Observatory (GDO))
- Estimated number of people with dementia living in residential long-term care (Global Dementia Observatory (GDO))
- Estimated percentage of residential long-term care facilities following national dementia standards (Global Dementia Observatory (GDO))
- Estimated number of people with dementia receiving services at outpatient health centre (Global Dementia Observatory (GDO))
- Estimated number of people with dementia receiving services at outpatient social centre (Global Dementia Observatory (GDO))
- Existence of dementia legislation (Global Dementia Observatory (GDO))
- Existence of other laws that apply to the rights of people with dementia (Global Dementia Observatory (GDO))
- Existence of legislation for supported decision making for people with dementia (Global Dementia Observatory (GDO))
- Existence of legislation to file appeals protecting the rights of people with dementia (Global Dementia Observatory (GDO))
- Existence of legislation to promote community-based services for people with dementia (Global Dementia Observatory (GDO))
- Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside (Global Dementia Observatory (GDO))
- Existence of legislation for advanced care directives for people with dementia (Global Dementia Observatory (GDO))
- Existence of legislation to end discrimination against people with dementia (Global Dementia Observatory (GDO))
- Existence of legislation to end discrimination against carers of people with dementia (Global Dementia Observatory (GDO))
- Existence of legislation to end coercieve practices for people with dementia (Global Dementia Observatory (GDO))
- Existence of dementia national plan (Global Dementia Observatory (GDO))
- Existence of dementia sub-national plan(s) (Global Dementia Observatory (GDO))
- Existence of a current dementia research plan/programme (Global Dementia Observatory (GDO))
- EXISTING GHO INDICATOR (SDG 9.5.1) Gross domestic R&D expenditure on health (health GERD) as a % of gross domestic product (GDP) (Global Dementia Observatory (GDO))
- Existence of dementia standards/ guidelines/ protocols (Global Dementia Observatory (GDO))
- Existence of approved government dementia standards/ guidelines/ protocols (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols for diagnosis of dementia (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols for management of dementia (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols of care in hospital for people with dementia (Global Dementia Observatory (GDO))
- Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia (Global Dementia Observatory (GDO))
- Existence of dementia-friendly initiative to improve accessibility of public spaces (Global Dementia Observatory (GDO))
- Existence of dementia-friendly initiative to improve accessibility of public transportation (Global Dementia Observatory (GDO))
- Existence of dementia-friendly initiative for assistance with home modification (Global Dementia Observatory (GDO))
- Existence of dementia-friendly initiative with assistive technology for loss of capacity (Global Dementia Observatory (GDO))
- Existence of dementia-friendly initiative supporting community places for older people (Global Dementia Observatory (GDO))
- Existence of dementia-friendly initiative supporting social opportunities (Global Dementia Observatory (GDO))
- Existence of dementia national nongovernmental organization (Global Dementia Observatory (GDO))
- Environmental and public health workers density (per 1000 population) (Health workforce)
- Existence of a national drink-driving law (Road Safety)
- Estimated MDR/RR-TB cases among notified pulmonary TB cases (Tuberculosis)
- Early initiation of breastfeeding (in the two or three years preceding the survey) (%) (Health Equity Monitor)
- Early initiation of breastfeeding (in the five years preceding the survey) (%) (Health Equity Monitor)
- Epidemiological data collection system for substance use disorders (Resources for Substance Use Disorders)
- Essential list of medicines (Resources for Substance Use Disorders)
- Essential list of medicines, pharmacotherapy for substance use disorders (Resources for Substance Use Disorders)
- Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis (Neglected tropical diseases)
- Excise duty (average) per hectolitre in Euros (Global Information System on Alcohol and Health)
- Excise tax on alcoholic beverages (Global Information System on Alcohol and Health)
- Excise tax as a per cent of the retail price of alcoholic beverages (Global Information System on Alcohol and Health)
- Excise tax as a per cent of the total retail price for 1 litre of pure alcohol (Global Information System on Alcohol and Health)
- Existence of standards (Public health and environment)
- Existence of national regulation (Public health and environment)
- Existence of subnational regulation (Public health and environment)
- Electric field (V/m) (Public health and environment)
- Electric field (kV/m) (Public health and environment)
- Electric field (kV/m) (Public health and environment)
- External health expenditure (EXT) as percentage of current health expenditure (CHE) (%) (Health financing)
- External health expenditure (EXT) per capita in PPP int$ (Health financing)
- External health expenditure (EXT) per capita in US$ (Health financing)
- Estimated antiretroviral therapy coverage among people living with HIV (%) (Universal health coverage)
- Estimates of rates of homicides per 100 000 population (Violence prevention)
- Early initiation of breastfeeding (%) (Global strategy for women's, children's and adolescents' health)
- Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs (Noncommunicable diseases)
- Existence of a national multisectoral commission, agency or mechanism for NCDs (Noncommunicable diseases)
- ex - expectation of life at age x (Mortality and global health estimates)
- Existence of a national motorcycle helmet law (Road Safety)
- Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach (Noncommunicable diseases)
- Existence of a register of patients who had rheumatic fever and rheumatic heart disease (Noncommunicable diseases)
- Establishment of National Coordination Centre (NCC) (Antimicrobial resistance (AMR))
- Establishment of national reference laboratory (NRL) (Antimicrobial resistance (AMR))
- EQA provided to the national reference laboratory (NRL) (Antimicrobial resistance (AMR))
- EQA provided for bacterial identification and AST (Antimicrobial resistance (AMR))
- EQA provided to local laboratories participating in GLASS (Antimicrobial resistance (AMR))
- Estimated number of people (all ages) living with HIV (HIV/AIDS)
- Existence of a set of time-bound national targets based on WHO guidance (Noncommunicable diseases)
- Existence of national policies on saturated fatty acids / trans-fats (Noncommunicable diseases)
- Existence of any policies to reduce population salt consumption (Noncommunicable diseases)
- Existence of any policies on marketing of foods to children (Noncommunicable diseases)
- Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan for cardiovascular diseases (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan for cancer (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan for diabetes (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan for chronic respiratory diseases (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan to reduce physical inactivity (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan to decrease tobacco use (Noncommunicable diseases)
- Existence of operational policy/strategy/action plan for oral health (Noncommunicable diseases)
- Existence of a universal access telephone number for pre-hospital care (Road Safety)
- Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission (HIV/AIDS)
- Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods (HIV/AIDS)
- Elder abuse: Extent of implementation of caregiver-support programmes (Violence prevention)
- Existence of national HPV vaccination programme (Noncommunicable diseases)
- Existence of national screening program for breast cancer (Noncommunicable diseases)
- Education facilities except universities (national legislation) (Noncommunicable diseases)
- Estimated population-based prevalence of depression (Global Dementia Observatory (GDO))
- Estimated number of road traffic deaths (Road Safety)
- Estimated road traffic death rate (per 100 000 population) (Road Safety)
- Existence of road safety audit for all new roads (Road Safety)
- Existence of road safety audit for existing roads (Road Safety)
- Existence of a national seat-belt law (Road Safety)
- Extent of implementation of mental health services for victims of all types of violence (Violence prevention)
- Extent of implementation of child protection services (Violence prevention)
- Extent of implementation of medico-legal services for victims of sexual violence (Violence prevention)
- Existence of national speed limits (Road Safety)
- Enforce bans on tobacco advertising (Noncommunicable diseases)
- Existence of a national road safety strategy (Road Safety)
- Existence of population-based cancer registry (Noncommunicable diseases)
- Existence of a diabetes registry (Noncommunicable diseases)
F
- Food safety (International Health Regulations (2005) monitoring framework)
- Formative research was conducted (Noncommunicable diseases)
- Free distribution in mail or through other means (Noncommunicable diseases)
- Fines for violations (Noncommunicable diseases)
- Fines on the establishment (Noncommunicable diseases)
- Fines on the patron (Noncommunicable diseases)
- Full immunization coverage among one-year-olds (%) (Health Equity Monitor)
- Financing method for substance use disorder treatment (Resources for Substance Use Disorders)
- Framework of national alcohol policy (Global Information System on Alcohol and Health)
- Funding method for substance use disorder prevention (Resources for Substance Use Disorders)
- Functioning national AMR surveillance plan (Antimicrobial resistance (AMR))
G
- General government expenditure on health as a percentage of total government expenditure (Health systems)
- Geriatric-specific hospital beds (per 10,000 population) (Global Dementia Observatory (GDO))
- Government benefits for alcohol use disorders, subsidy or disability pension (Resources for Substance Use Disorders)
- Government benefits for drug use disorders, subsidy or disability pension (Resources for Substance Use Disorders)
- Governement benefits for persons with substance use disorders (Resources for Substance Use Disorders)
- Government support for community action (Global Information System on Alcohol and Health)
- Government unit for substance use disorder prevention (Resources for Substance Use Disorders)
- Government unit for substance use disorder treatment (Resources for Substance Use Disorders)
- Groups and agencies for the prevention of substance use disorders (Resources for Substance Use Disorders)
- Guidelines on the pharmacological treatment of substance use disorders (Resources for Substance Use Disorders)
- Government expenditures on mental health as a percentage of total government expenditures on health (%) (Mental health)
- Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%) (Mental health)
- General availability of sulphonylurea(s) in the public health sector (Noncommunicable diseases)
- General availability of bronchodilators in the public health sector (Noncommunicable diseases)
- General availability of insulin in the public health sector (Noncommunicable diseases)
- General availability of aspirin (100 mg) in the public health sector (Noncommunicable diseases)
- General availability of metformin in the public health sector (Noncommunicable diseases)
- General availability of glibenclamide in the public health sector (Noncommunicable diseases)
- General availability of thiazide diuretics in the public health sector (Noncommunicable diseases)
- General availability of ACE inhibitors in the public health sector (Noncommunicable diseases)
- General availability of CC blockers in the public health sector (Noncommunicable diseases)
- General availability of beta blockers in the public health sector (Noncommunicable diseases)
- General availability of beta blockers in the public health sector (Noncommunicable diseases)
- General availability of tamoxifen in the public health sector (Noncommunicable diseases)
- General availability of statins in the public health sector (Noncommunicable diseases)
- General availability of oral morphine in the public health sector (Noncommunicable diseases)
- General availability of nicotine replacement therapy in the public health sector (Noncommunicable diseases)
- General availability of salbutamol in the public health sector (Noncommunicable diseases)
- General availability of prednisolone tabs in the public health sector (Noncommunicable diseases)
- General availability of steroid inhalers in the public health sector (Noncommunicable diseases)
- General availability of hydrocortisone injections in the public health sector (Noncommunicable diseases)
- General availability of ipratropium bromide in the public health sector (Noncommunicable diseases)
- General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level (Noncommunicable diseases)
- General availability of diabetes testing (by HbA1c) at the primary health care level (Noncommunicable diseases)
- General availability of urine testing for albumin (Noncommunicable diseases)
- General availability of total cholesterol measurement at the primary health care level (Noncommunicable diseases)
- General availability of peak flow measurement spirometry at the primary health care level (Noncommunicable diseases)
- GLASS pathogens testing covered by EQA (Antimicrobial resistance (AMR))
- Government objectives on tobacco control exist (Noncommunicable diseases)
- General availability of palliative care in community or home-based care in the public health system (Noncommunicable diseases)
- General availability of palliative care in primary health care in the public health system (Noncommunicable diseases)
- General availability of retinal photocoagulation in the public health system (Noncommunicable diseases)
- General availability of dialysis in the public health system (Noncommunicable diseases)
- General availability of renal replacement by transplantation in the public health system (Noncommunicable diseases)
- General availability of coronary bypass or stenting in the public health system (Noncommunicable diseases)
- General availability of thrombolytic therapy in the public health system (Noncommunicable diseases)
- Government monopoly on production (Global Information System on Alcohol and Health)
- Government facilities (national legislation) (Noncommunicable diseases)
- Government monopoly on retail sales (Global Information System on Alcohol and Health)
H
- Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package (Noncommunicable diseases)
- Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry (Noncommunicable diseases)
- Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale (Noncommunicable diseases)
- Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps (Noncommunicable diseases)
- Health warnings on cigarette packaging law requires or establishes fines for violations (Noncommunicable diseases)
- Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package (Noncommunicable diseases)
- Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry (Noncommunicable diseases)
- Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale (Noncommunicable diseases)
- Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps (Noncommunicable diseases)
- Health warnings on other smoked tobacco packaging law requires or establishes fines for violations (Noncommunicable diseases)
- Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package (Noncommunicable diseases)
- Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry (Noncommunicable diseases)
- Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale (Noncommunicable diseases)
- Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps (Noncommunicable diseases)
- Health warnings on smokeless tobacco packaging law requires or establishes fines for violations (Noncommunicable diseases)
- Human resources (International Health Regulations (2005) monitoring framework)
- Household air pollution attributable deaths (Public health and environment)
- Household air pollution attributable DALYs (Public health and environment)
- HIV-positive TB patients on ART (antiretroviral therapy) (%) (Tuberculosis)
- Household air pollution attributable mortality rate (attributable deaths per 100 000?) (Public health and environment)
- Household air pollution attributable mortality rate (attributable deaths per 100 000?, age-standardized) (Public health and environment)
- Hospice centre beds (per 10 000 population) (Global Dementia Observatory (GDO))
- Hospital beds (per 10 000 population) (Global Dementia Observatory (GDO))
- Health management & support workers density (per 1000 population) (Health workforce)
- Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) (Universal health coverage)
- Hib (Hib3) immunization coverage among 1-year-olds (%) (Universal health coverage)
- HIV prevalence (Urban health)
- Harm reduction programmes for IDUs (Resources for Substance Use Disorders)
- Health professionals mostly involved in treatment of substance use disorders (Resources for Substance Use Disorders)
- Health technology (medical device) national policy (Priority health technologies)
- Health warning labels on alcohol advertising (Global Information System on Alcohol and Health)
- Health warning labels on alcohol containers (Global Information System on Alcohol and Health)
- How many health warnings are approved by the law for cigarette packaging? (Noncommunicable diseases)
- How many health warnings are approved by the law for other smoked tobacco packaging? (Noncommunicable diseases)
- How many health warnings are approved by the law for smokeless tobacco packaging? (Noncommunicable diseases)
- Healthy life expectancy (HALE) at birth (years) (Mortality and global health estimates)
- Healthy life expectancy (HALE) at age 60 (years) (Mortality and global health estimates)
- Households that use solid fuels for cooking (%) (Urban health)
- Households with at least one ITN for sleeping (%) (Urban health)
- Households that have a bednet for sleeping (%) (Urban health)
- Households using an improved drinking-water source (%) (Urban health)
- Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease (Noncommunicable diseases)
- Households using a piped onto premises drinking-water source (%) (Urban health)
- Health-care facilities (national legislation) (Noncommunicable diseases)
- Has a STEPS survey or a comprehensive health examination survey every 5 years (Noncommunicable diseases)
I
- International television and radio (Noncommunicable diseases)
- International magazines and newspapers (Noncommunicable diseases)
- Internet (Noncommunicable diseases)
- Importance of measures for enhancing compliance with age limits (Global Information System on Alcohol and Health)
- Ill-defined causes in cause-of-death registration (%) (Health systems)
- Implementation level [national/subnational] of dementia awareness campaign (Global Dementia Observatory (GDO))
- Implementation level [national/subnational] of dementia risk reduction campaign (Global Dementia Observatory (GDO))
- Implementation level [national/subnational] of dementia care coordination (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Health) (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Social) (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Education) (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Employment) (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Justice) (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Housing) (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Civil society) (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Private sector) (Global Dementia Observatory (GDO))
- Identification of different sectors in dementia care coordination (Other) (Global Dementia Observatory (GDO))
- Implementation level [national/subnational] of dementia carer support services (Global Dementia Observatory (GDO))
- Inclusion of dementia training and education for non-health workers (Global Dementia Observatory (GDO))
- Inclusion of dementia in ministry portfolio (Global Dementia Observatory (GDO))
- Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease] (Global Dementia Observatory (GDO))
- Inclusion of basic dementia competencies in training of physicians (Global Dementia Observatory (GDO))
- Inclusion of basic dementia competencies in training of specialists (Global Dementia Observatory (GDO))
- Inclusion of basic dementia competencies in training of nurses (Global Dementia Observatory (GDO))
- Inclusion of basic dementia competencies in training of pharmaceutical personnel (Global Dementia Observatory (GDO))
- Inclusion of basic dementia competencies in training of social workers (Global Dementia Observatory (GDO))
- Inclusion of basic dementia competencies in training of personal support workers (Global Dementia Observatory (GDO))
- Implementation level [national/subnational] of dementia legislation (Global Dementia Observatory (GDO))
- Identification of other plans in which dementia is integrated (Mental health) (Global Dementia Observatory (GDO))
- Identification of other plans in which dementia is integrated (Ageing) (Global Dementia Observatory (GDO))
- Identification of other plans in which dementia is integrated (NCD) (Global Dementia Observatory (GDO))
- Identification of other plans in which dementia is integrated (Disability) (Global Dementia Observatory (GDO))
- Identification of other plans in which dementia is integrated (Other) (Global Dementia Observatory (GDO))
- Inclusion of human rights as a guiding principle of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of equity as a guiding principle of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of empowerment as a guiding principle of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of multisectoral collaboration as a guiding principles of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of universal health coverage as a guiding principle of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of dementia-friendly communities as a specific action of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of dementia risk reduction as a specific action of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of dementia workforce training as a specific action of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of support for dementia carers and families as a specific action of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of improved information system as a specific action of the dementia plan (Global Dementia Observatory (GDO))
- Inclusion of research and innovation as a specific action of the dementia plan (Global Dementia Observatory (GDO))
- Implementation level [national/subnational] of dementia research plan/programme (Global Dementia Observatory (GDO))
- Identification of other research plans in which dementia is integrated (Mental health) (Global Dementia Observatory (GDO))
- Identification of other research plans in which dementia is integrated (Ageing) (Global Dementia Observatory (GDO))
- Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease) (Global Dementia Observatory (GDO))
- Identification of other research plans in which dementia is integrated (NCD) (Global Dementia Observatory (GDO))
- Implementation level [national/subnational] of research plan in which dementia is integrated (Global Dementia Observatory (GDO))
- Implementation level of dementia standards/ guidelines/ protocols (National) (Global Dementia Observatory (GDO))
- Implementation level of dementia standards/ guidelines/ protocols (Sub-national) (Global Dementia Observatory (GDO))
- Infant mortality rate (deaths per 1000 live births) (Health Equity Monitor)
- Intimate partner violence prevalence among ever partnered women (%) (Global strategy for women's, children's and adolescents' health)
- Incidence of tuberculosis (per 100 000 population per year) (Tuberculosis)
- Incidence of tuberculosis (per 100 000 population) (HIV-positive cases) (Tuberculosis)
- Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%) (Universal health coverage)
- Increase in poverty gap due to household health expenditures at the $1.90 a day poverty line, in cents of international dollars (Universal health coverage)
- Increase in poverty gap due to household health expenditures, expressed as a proportion of the 3.10 a-day poverty line (%) (Universal health coverage)
- Increase in poverty gap due to household health expenditures at the $3.10a day poverty line, in cents of international dollars (Universal health coverage)
- Infant mortality per 1 000 live births (Urban health)
- Infants exclusively breastfed for the first six months of life (%) (Child health)
- Information requirements (Public health and environment)
- Implementation of physical activity public awareness program (Noncommunicable diseases)
- Insufficiently active (crude estimate) (Global strategy for women's, children's and adolescents' health)
- Insufficiently active (crude estimate) (Noncommunicable diseases)
- Intimate partner violence: Extent of implementation of dating violence prevention programmes (Violence prevention)
- Indoor offices (national legislation) (Noncommunicable diseases)
- Insufficiently active (age-standardized estimate) (Global Dementia Observatory (GDO))
- Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) (Global strategy for women's, children's and adolescents' health)
J
K
L
- Level of taxation adjusted for inflation (Global Information System on Alcohol and Health)
- Liver cirrhosis, age-standardized death rates (15+), per 100,000 population (Global Information System on Alcohol and Health)
- Legislation (International Health Regulations (2005) monitoring framework)
- Laboratory (International Health Regulations (2005) monitoring framework)
- Local magazines and newspapers (Noncommunicable diseases)
- Law requires fines for violations of direct advertising bans (Noncommunicable diseases)
- Law requires fines for violations of indirect advertising bans (Noncommunicable diseases)
- Lifetime prevalence of child physical abuse (%) (Violence prevention)
- Lifetime prevalence of child emotional abuse (%) (Violence prevention)
- Lifetime prevalence of child sexual abuse (%) (Violence prevention)
- Lifetime prevalence of child physical neglect (%) (Violence prevention)
- Legislative provision for compulsory treatment (Resources for Substance Use Disorders)
- Laboratory health workers density (per 1000 population) (Health workforce)
- Law mandates that health warnings appear on tobacco packages (Noncommunicable diseases)
- Law mandates that health warnings appear on other smoked tobacco packages (Noncommunicable diseases)
- Law mandates that health warnings appear on smokeless tobacco packages (Noncommunicable diseases)
- Length of stay for inpatient detoxification, days (Resources for Substance Use Disorders)
- Length of stay for inpatient long-term residential treatment, days (Resources for Substance Use Disorders)
- Length of stay for inpatient short-term treatment, days (Resources for Substance Use Disorders)
- Legally binding lead controls (Public health and environment)
- Legal blood alcohol concentration (BAC) limits (Global Information System on Alcohol and Health)
- Legal obligation for schools to interact with parents regarding education and well-being (Global Information System on Alcohol and Health)
- Legal obligation for schools to include alcohol use prevention (Global Information System on Alcohol and Health)
- Legislation on alcohol testing at workplaces (Global Information System on Alcohol and Health)
- Level of adoption of national alcohol policy (Global Information System on Alcohol and Health)
- Life expectancy at birth (years) (Women and health)
- Life expectancy at age 60 (years) (Women and health)
- lx - number of people left alive at age x (Mortality and global health estimates)
- Law requires helmet to be fastened (Road Safety)
- Leprosy - number of reported cases (Neglected tropical diseases)
- Licence required for production (Global Information System on Alcohol and Health)
- Licence required for retail sales (Global Information System on Alcohol and Health)
- Legislative provision for treatment and rehabilitation of substance use disorders (Resources for Substance Use Disorders)
M
- Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (Public health and environment)
- Most widely used screening method in national cervical cancer screening program (Universal health coverage)
- Most sold brand of cigarettes - currency reported (Noncommunicable diseases)
- Most sold brand of cigarettes - price in currency reported (Noncommunicable diseases)
- Most sold brand of cigarettes - price in international dollars (Noncommunicable diseases)
- Most sold brand of cigarettes - price in US$ at official exchange rates (Noncommunicable diseases)
- Most sold brand of cigarettes - taxes as a % of price - specific excise (Noncommunicable diseases)
- Most sold brand of cigarettes - taxes as a % of price - ad valorem excise (Noncommunicable diseases)
- Most sold brand of cigarettes - taxes as a % of price - import duties (Noncommunicable diseases)
- Most sold brand of cigarettes - taxes as a % of price - value added tax (Noncommunicable diseases)
- Most sold brand of cigarettes - taxes as a % of price - other taxes (Noncommunicable diseases)
- Most sold brand of cigarettes - taxes as a % of price - total tax (Noncommunicable diseases)
- Majority provider of activities of daily living support services in community for dementia [public, private] (Global Dementia Observatory (GDO))
- Majority provider of behaviour and psychological management in community for dementia [public, private] (Global Dementia Observatory (GDO))
- Majority provider of diagnostic services in community for dementia [public, private] (Global Dementia Observatory (GDO))
- Majority provider of palliative and end-of-life care services in community for dementia [public, private] (Global Dementia Observatory (GDO))
- Majority provider of psychosocial and rehabilitation services in community for dementia [public, private] (Global Dementia Observatory (GDO))
- Majority provider of social and financial protection for dementia [public, private] (Global Dementia Observatory (GDO))
- Majority provider of dementia carer training and education (Public sector) (Global Dementia Observatory (GDO))
- Majority provider of dementia carer training and education (Private sector) (Global Dementia Observatory (GDO))
- Majority provider of dementia carer training and education (NGO) (Global Dementia Observatory (GDO))
- Majority provider of information on financial benefits/social protection for dementia carers (Public sector) (Global Dementia Observatory (GDO))
- Majority provider of information on financial benefits/social protection for dementia carers (Private sector) (Global Dementia Observatory (GDO))
- Majority provider of information on financial benefits/social protection for dementia carers (NGO) (Global Dementia Observatory (GDO))
- Majority provider of information on legal rights for dementia carers (Public sector) (Global Dementia Observatory (GDO))
- Majority provider of information on legal rights for dementia carers (Private sector) (Global Dementia Observatory (GDO))
- Majority provider of information on legal rights for dementia carers (NGO) (Global Dementia Observatory (GDO))
- Majority provider of psycho-social supports for dementia carers (Public sector) (Global Dementia Observatory (GDO))
- Majority provider of psycho-social supports for dementia carers (Private sector) (Global Dementia Observatory (GDO))
- Majority provider of psycho-social supports for dementia carers (NGO) (Global Dementia Observatory (GDO))
- Majority provider of respite care for dementia carers (Public sector) (Global Dementia Observatory (GDO))
- Majority provider of respite care for dementia carers (Private sector) (Global Dementia Observatory (GDO))
- Majority provider of respite care for dementia carers (NGO) (Global Dementia Observatory (GDO))
- Measles immunization coverage among one-year-olds (%) (Health Equity Monitor)
- Magnetic flux density (microT) (Public health and environment)
- Mental health outpatient facilities (per 100,000) (Mental health)
- Mental health day treatment facilities (per 100,000) (Mental health)
- Mental hospitals (per 100,000) (Mental health)
- Mental health units in general hospitals (per 100,000) (Mental health)
- Mental hospital admissions (per 100,000) (Mental health)
- Mental health units in general hospitals admissions (per 100,000) (Mental health)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (Universal health coverage)
- Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%) (Universal health coverage)
- Malaria incidence (per 1 000 population at risk) (Global strategy for women's, children's and adolescents' health)
- Maternal mortality ratio (per 100 000 live births) (Global strategy for women's, children's and adolescents' health)
- Maximum speed limits (Road Safety)
- Mean BMI (kg/m²) (age-standardized estimate) (Noncommunicable diseases)
- Mean BMI (kg/m²) (crude estimate) (Noncommunicable diseases)
- Mean systolic blood pressure (age-standardized estimate) (Noncommunicable diseases)
- Mean Total Cholesterol (age-standardized estimate) (Noncommunicable diseases)
- Mean Total Cholesterol (crude estimate) (Noncommunicable diseases)
- Measles - number of reported cases (Vaccine-preventable communicable diseases)
- Median availability of selected generic medicines (%) - Public (Essential medicines)
- Median availability of selected generic medicines (%) - Private (Essential medicines)
- Median consumer price ratio of selected generic medicines - Public (Essential medicines)
- Median consumer price ratio of selected generic medicines - Private (Essential medicines)
- Men who have sex with men (MSM) with active syphilis (%) (Sexually Transmitted Infections)
- Mental health policy (Mental health)
- Mental health plan (Mental health)
- Methadone formulation used for the treatment of opiod dependence (Resources for Substance Use Disorders)
- Methadone provision in clinical and community-based settings (Resources for Substance Use Disorders)
- Methadone used for the treatment of opioid dependence (Resources for Substance Use Disorders)
- Methadone used for detoxification or maintenance (Resources for Substance Use Disorders)
- Mortality rate attributed to household and ambient air pollution (per 100 000 population) (Global strategy for women's, children's and adolescents' health)
- Motorcycle helmet wearing rate (%) (Road Safety)
- Mumps - number of reported cases (Vaccine-preventable communicable diseases)
- Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) (Mortality and global health estimates)
- Monitor (Noncommunicable diseases)
- Mortality rate attributed to unintentional poisoning (per 100 000 population) (Public health and environment)
- Married or in-union women of reproductive age who have their need for family planning satisfied with modern methods (%) (Global strategy for women's, children's and adolescents' health)
N
- Number of physicians (Health workforce)
- Number of nursing and midwifery personnel (Health workforce)
- Number of dentistry personnel (Health workforce)
- Number of pharmaceutical personnel (Health workforce)
- Number of laboratory health workers (Health workforce)
- Number of environment and public health workers (Health workforce)
- Number of community and traditional health workers (Health workforce)
- Number of other health workers (Health workforce)
- Number of health management & support workers (Health workforce)
- National regulator approval of anti-dementia medication (Global Dementia Observatory (GDO))
- National television and radio (Noncommunicable diseases)
- Non-tobacco products identified with tobacco brand names (Noncommunicable diseases)
- Number of places smoke-free (national legislation) (Noncommunicable diseases)
- Number of community health workers (Health workforce)
- Number of traditional birth attendants (Health workforce)
- Number of traditional medicine practitioners (Health workforce)
- Number of deaths attributed to non-communicable diseases, by type of disease and sex (Noncommunicable diseases)
- Nursing and midwifery personnel density (per 1000 population) (Global Dementia Observatory (GDO))
- Number of personal care workers (Global Dementia Observatory (GDO))
- Number of neurologists (per 100,000) (Global Dementia Observatory (GDO))
- Number of geriatricians or psychogeriatricians (per 100,000) (Global Dementia Observatory (GDO))
- Number of people with dementia involved in research routinely monitored (Global Dementia Observatory (GDO))
- Number of investigational pharmaceutical trials for dementia (Global Dementia Observatory (GDO))
- Number of dentists (Health workforce)
- Number of dental technicians/assistants (Health workforce)
- New cases tested for RR-/MDR-TB (%) (Tuberculosis)
- Neonatal mortality rate (deaths per 1000 live births) (Health Equity Monitor)
- Neonates protected at birth against neonatal tetanus (PAB) (%) (Universal health coverage)
- Nurses working in mental health sector (per 100,000) (Mental health)
- Number of incident tuberculosis cases (Tuberculosis)
- Number of incident tuberculosis cases, (HIV-positive cases) (Tuberculosis)
- National alcohol policy specifically involves young people activities (Global Information System on Alcohol and Health)
- Number of laboratory scientists (Health workforce)
- Number of laboratory technicians/assistants (Health workforce)
- Number of radiographers (Health workforce)
- National legislation to prevent illegal alcohol (Global Information System on Alcohol and Health)
- nMx - age-specific death rate between ages x and x+n (Mortality and global health estimates)
- nqx - probability of dying between ages x and x+n (Mortality and global health estimates)
- ndx - number of people dying between ages x and x+n (Mortality and global health estimates)
- nLx - person-years lived between ages x and x+n (Mortality and global health estimates)
- Number of maternal deaths (Global strategy for women's, children's and adolescents' health)
- Number of medical assistants (Health workforce)
- Nicotine replacement therapy - legally sold (Noncommunicable diseases)
- Nicotine replacement therapy - place available (Noncommunicable diseases)
- Nicotine replacement therapy - cost covered (Noncommunicable diseases)
- Nicotine replacement therapy on the Essential Medicines List (Noncommunicable diseases)
- Number of deaths due to tuberculosis, excluding HIV (Tuberculosis)
- NGOs for alcohol use disorders (Resources for Substance Use Disorders)
- NGOs for drug use disorders (Resources for Substance Use Disorders)
- Number of national surveillance sites in each country providing data to GLASS: hospital category (Antimicrobial resistance (AMR))
- Number of National surveillance sites in each country providing data to GLASS: outpatient facility category (Antimicrobial resistance (AMR))
- Number of local clinical laboratories in each country performing AST to support national AMR surveillance sites (Antimicrobial resistance (AMR))
- Nomination of National Focal Point (NFP) (Antimicrobial resistance (AMR))
- National guidelines for implementing effective community-based interventions (Global Information System on Alcohol and Health)
- National guidelines for the prevention and reduction of alcohol-related harm in schools (Global Information System on Alcohol and Health)
- National guidelines for alcohol problem prevention and counselling at workplaces (Global Information System on Alcohol and Health)
- National survey on substance use among children and adolescents (Resources for Substance Use Disorders)
- National surveys on adult alcohol consumption (Global Information System on Alcohol and Health)
- National surveys on heavy espisodic drinking (Global Information System on Alcohol and Health)
- National surveys on youth alcohol consumption (Global Information System on Alcohol and Health)
- National sytems for monitoring alcohol consumption and harms (Global Information System on Alcohol and Health)
- National agency for tobacco control exists (Noncommunicable diseases)
- Number of full-time equivalent staff in national agency (Noncommunicable diseases)
- Neonatal tetanus - number of reported cases (Vaccine-preventable communicable diseases)
- New or unknown treatment history cases: Pulmonary, bacteriologically confirmed (Tuberculosis)
- New or unknown treatment history cases: Pulmonary, clinically diagnosed (Tuberculosis)
- New cases: Pulmonary, smear-positive (Tuberculosis)
- New cases: Pulmonary, smear-negative/unknown/not done and other new cases (Tuberculosis)
- New cases: extrapulmonary (Tuberculosis)
- New types of alcoholic beverages emerging (Global Information System on Alcohol and Health)
- Neonatal mortality rate (per 1000 live births) (Global strategy for women's, children's and adolescents' health)
- Non-partner sexual violence prevalence (%) (Violence against women)
- Number of cases of cutaneous leishmaniasis reported (Neglected tropical diseases)
- Number of imported cases of cutaneous leishmaniasis reported (Neglected tropical diseases)
- Number of cases of visceral leishmaniasis reported (Neglected tropical diseases)
- Number of cases of yaws reported (Neglected tropical diseases)
- Number of under-five deaths (thousands) (Mortality and global health estimates)
- Number of infant deaths (thousands) (Mortality and global health estimates)
- Number of neonatal deaths (thousands) (Mortality and global health estimates)
- Number of deaths due to HIV/AIDS (HIV/AIDS)
- Number of imported cases of visceral leishmaniasis reported (Neglected tropical diseases)
- Number of meningitis epidemic districts (Meningococcal meningitis)
- New HIV infections among adults 15-24 years old (per 1000 uninfected population) (Global strategy for women's, children's and adolescents' health)
- Number of new HIV infections (Global strategy for women's, children's and adolescents' health)
- New HIV infections (per 1000 uninfected population) (Global strategy for women's, children's and adolescents' health)
- Number of new reported cases of human African trypanosomiasis (T.b. gambiense) (Neglected tropical diseases)
- Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense) (Neglected tropical diseases)
- Number of new reported cases of Buruli ulcer (Neglected tropical diseases)
- Number of people operated for trachomatous trichiasis (Neglected tropical diseases)
- Number of people who received treatment with antibiotics for trachoma (Neglected tropical diseases)
- Number of reported cases of cholera (Cholera)
- Number of reported deaths from cholera (Cholera)
- Number of standard alcoholic drinks displayed on containers (Global Information System on Alcohol and Health)
- Number of suspected meningitis cases reported (Meningococcal meningitis)
- Number of suspected meningitis deaths reported (Meningococcal meningitis)
- Number of nursing personnel (Health workforce)
- Number of midwifery personnel (Health workforce)
- Number of people aged 15 years and over who received HIV testing and counselling, reported number (HIV/AIDS)
- Number of people aged 15 years and over who received HIV testing and counselling, reporting period (HIV/AIDS)
- Number of pharmacists (Health workforce)
- Number of pharmaceutical technicians/assistants (Health workforce)
- NCD deaths under age 70 (percent of all NCD deaths) (Noncommunicable diseases)
- Name of survey of adults - smokeless (Noncommunicable diseases)
- Name of survey of adults (Noncommunicable diseases)
- Name of survey of youth (Noncommunicable diseases)
- Name of survey of youth - smokeless (Noncommunicable diseases)
- Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission (HIV/AIDS)
- National guidelines, policies or recommendations on the procurement of medical devices (Priority health technologies)
- Number of registered vehicles (Road Safety)
- Number of deaths attributed to suicide, total and by sex (Mental health)
- Number of licensed qualified surgeons actively working (Health workforce)
- Number of licensed qualified obstetricians actively working (Health workforce)
- Number of licensed qualified anaesthesiologists actively working (Health workforce)
- Number of deaths (Mortality and global health estimates)
O
- Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors (Noncommunicable diseases)
- Other smoked tobacco packaging and labelling must not use descriptors depicting flavours (Noncommunicable diseases)
- Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark (Noncommunicable diseases)
- Other smoked tobacco packaging and labelling must display qualitative information on relevant constituents and emissions (Noncommunicable diseases)
- Other smoked tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas (Noncommunicable diseases)
- Other smoked tobacco packaging and labelling must not display expiry dates (Noncommunicable diseases)
- Occupational airborne particulates attributable deaths (Public health and environment)
- Occupational airborne particulates attributable DALYs ('000) (Public health and environment)
- Occupational airborne particulates attributable deaths per 100'000 capita (Public health and environment)
- Occupational airborne particulates attributable DALYs per 100'000 capita (Public health and environment)
- Outcome evaluation was employed to assess effectiveness (Noncommunicable diseases)
- Occupational carcinogens attributable deaths (Public health and environment)
- Occupational carcinogens attributable DALYs ('000) (Public health and environment)
- Occupational carcinogens attributable deaths per 100'000 capita (Public health and environment)
- Occupational carcinogens attributable DALYs per 100'000 capita (Public health and environment)
- Off-premise sales restrictions on days (Global Information System on Alcohol and Health)
- On-premise sales restrictions on days (Global Information System on Alcohol and Health)
- Outpatient health centres (Global Dementia Observatory (GDO))
- Outpatient social centres (Global Dementia Observatory (GDO))
- Other health workers density (per 1000 population) (Health workforce)
- Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%) (Health Equity Monitor)
- Occupational ergonomic stressors attributable deaths (Public health and environment)
- Occupational ergonomic stressors attributable DALYs ('000) (Public health and environment)
- Occupational ergonomic stressors attributable deaths per 100'000 capita (Public health and environment)
- Occupational ergonomic stressors attributable DALYs per 100'000 capita (Public health and environment)
- Outpatient visits (per 100,000) (Mental health)
- Overweight prevalence (Child malnutrition)
- Overweight numbers (in millions) (Child malnutrition)
- Off-premise sales restrictions on hours (Global Information System on Alcohol and Health)
- On-premise sales restrictions on hours (Global Information System on Alcohol and Health)
- Occupational therapists in mental health sector (per 100,000) (Mental health)
- Other non-specialized doctors in mental health sector (per 100,000) (Mental health)
- On-premise sales restrictions to intoxicated persons (Global Information System on Alcohol and Health)
- Occupational noise attributable DALYs ('000) (Public health and environment)
- Occupational noise attributable DALYs per 100'000 capita (Public health and environment)
- Open access services for substance use disorders (Resources for Substance Use Disorders)
- Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance) (Resources for Substance Use Disorders)
- Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance) (Resources for Substance Use Disorders)
- Out-of-pocket expenditure (OOP) per capita in PPP int$ (Health financing)
- Out-of-pocket expenditure (OOP) per capita in US$ (Health financing)
- Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%) (Health financing)
- Out-of-pocket expenditure as a percentage of total expenditure on health (Global strategy for women's, children's and adolescents' health)
- Off-premise sales restrictions on outlet density (Global Information System on Alcohol and Health)
- On-premise sales restrictions on outlet density (Global Information System on Alcohol and Health)
- Off-premise sales restrictions at petrol stations (Global Information System on Alcohol and Health)
- Off-premise sales restrictions on places (Global Information System on Alcohol and Health)
- On-premise sales restrictions on places (Global Information System on Alcohol and Health)
- Occupational injuries attributable deaths (Public health and environment)
- Occupational injuries attributable DALYs ('000) (Public health and environment)
- Occupational injuries attributable deaths per 100'000 capita (Public health and environment)
- Occupational injuries attributable DALYs per 100'000 capita (Public health and environment)
- Off-premise sales restrictions at specific events (Global Information System on Alcohol and Health)
- On-premise sales restrictions at specific events (Global Information System on Alcohol and Health)
- Offer help to quit tobacco use (Noncommunicable diseases)
P
- Publicity of corporate social responsibility activities by tobacco companies (Noncommunicable diseases)
- Publicity of corporate social responsibility activities by other entities (Noncommunicable diseases)
- Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). (Noncommunicable diseases)
- Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). (Noncommunicable diseases)
- Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). (Noncommunicable diseases)
- Population using at least basic sanitation services (%) (Universal health coverage)
- Pharmacotherapy used for the management of alcohol withdrawal (Resources for Substance Use Disorders)
- Preparedness (International Health Regulations (2005) monitoring framework)
- Points of entry (International Health Regulations (2005) monitoring framework)
- Prevalence of anaemia in children under 5 years (%) (Child malnutrition)
- Process evaluation was employed to assess implementation (Noncommunicable diseases)
- Prices for alcoholic beverages (average, US$) (Global Information System on Alcohol and Health)
- Point of sale (Noncommunicable diseases)
- Promotional discounts (Noncommunicable diseases)
- Pharmacotherapy used for the management of benzodiazepine withdrawal (Resources for Substance Use Disorders)
- Prescription requirements for buprenorphine (Resources for Substance Use Disorders)
- Prescription requirements for buprenorphine/naloxone (Resources for Substance Use Disorders)
- Pharmacotherapy used for the management of cannabis withdrawal (Resources for Substance Use Disorders)
- Population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (%) (Universal health coverage)
- Population with household expenditures on health greater than 25% of total household expenditure or income ( SDG indicator 3.8.2) (%) (Universal health coverage)
- Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%) (Global strategy for women's, children's and adolescents' health)
- Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%) (Global strategy for women's, children's and adolescents' health)
- Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%) (Global strategy for women's, children's and adolescents' health)
- Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%) (Global strategy for women's, children's and adolescents' health)
- Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%) (Global strategy for women's, children's and adolescents' health)
- Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%) (Global strategy for women's, children's and adolescents' health)
- Proportion of children aged 6-23 months who receive a minimum acceptable diet (Global strategy for women's, children's and adolescents' health)
- Premium brand of cigarettes - currency reported (Noncommunicable diseases)
- Premium brand of cigarettes - price in currency reported (Noncommunicable diseases)
- Premium brand of cigarettes - price in international dollars (Noncommunicable diseases)
- Premium brand of cigarettes - price in US$ at official exchange rates (Noncommunicable diseases)
- Presence of formal agreement/joint plan for dementia care coordination (Global Dementia Observatory (GDO))
- Physicians density (per 1000 population) (Global Dementia Observatory (GDO))
- Pharmaceutical personnel density (per 1000 population) (Global Dementia Observatory (GDO))
- Psychiatrists working in mental health sector (per 100,000) (Global Dementia Observatory (GDO))
- Percentage of sub-national regions covered by dementia plan (Global Dementia Observatory (GDO))
- Provision of governmental funding to dementia nongovernmental organization for activities/services (Global Dementia Observatory (GDO))
- Previously treated cases tested for RR-/MDR-TB (%) (Tuberculosis)
- Pregnant women sleeping under insecticide-treated nets (%) (Health Equity Monitor)
- Polio immunization coverage among one-year-olds (%) (Health Equity Monitor)
- Population using improved drinking-water sources (%) (Public health and environment)
- Population using improved sanitation facilities (%) (Public health and environment)
- Percentage of children under 15 years exposed to second-hand smoke (Public health and environment)
- Percentage of women (15+ years) exposed to second-hand smoke (Public health and environment)
- Percentage of men (15+ years) exposed to second-hand smoke (Public health and environment)
- Power density (W/m^2) (Public health and environment)
- Power frequency (Hz) (Public health and environment)
- Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting (FMG/C) (%) (Global strategy for women's, children's and adolescents' health)
- Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%) (Universal health coverage)
- Polio (Pol3) immunization coverage among 1-year-olds (%) (Universal health coverage)
- Population with basic handwashing facilities at home (%) (Public health and environment)
- Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging (Noncommunicable diseases)
- Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging (Noncommunicable diseases)
- Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging (Noncommunicable diseases)
- Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging (Noncommunicable diseases)
- Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging (Noncommunicable diseases)
- Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging (Noncommunicable diseases)
- Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging (Noncommunicable diseases)
- Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging (Noncommunicable diseases)
- Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging (Noncommunicable diseases)
- Psychologists working in mental health sector (per 100,000) (Mental health)
- Programmes diverting clients from the justice system towards treatment (Resources for Substance Use Disorders)
- Proportion of young women and men aged 18-29 years who experienced sexual violence by age 18 (%) (Global strategy for women's, children's and adolescents' health)
- Prescription requirements for methadone (Resources for Substance Use Disorders)
- Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease (Global strategy for women's, children's and adolescents' health)
- Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities (Noncommunicable diseases)
- Prevalence of obesity (Urban health)
- Population practising open defecation (%) (Public health and environment)
- Prevalence of (moderate or severe) overweight in children (Urban health)
- Participation rate in organized learning (one year before the official primary entry age) (%) (Global strategy for women's, children's and adolescents' health)
- Penalties for drink driving (Global Information System on Alcohol and Health)
- Penalties for marketing infringements (Global Information System on Alcohol and Health)
- People aged 15 years and over who received HIV testing and counselling, estimated number per 1000 adult population (HIV/AIDS)
- Policy documents on the pharmacological treatment of substance use disorders (Resources for Substance Use Disorders)
- Poliomyelitis - number of reported cases (Vaccine-preventable communicable diseases)
- Population (in thousands) total (Demographic and socioeconomic statistics)
- Population median age (years) (Demographic and socioeconomic statistics)
- Population proportion under 15 (%) (Demographic and socioeconomic statistics)
- Population proportion over 60 (%) (Demographic and socioeconomic statistics)
- Population living in urban areas (%) (Demographic and socioeconomic statistics)
- Population living on <$1 (PPP int. $) a day (%) (Demographic and socioeconomic statistics)
- Proportion of population below the international poverty line of US$1.90 per day (%) (Global strategy for women's, children's and adolescents' health)
- Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem (Neglected tropical diseases)
- Population not using any sanitation facility (open defecation) (%) (Urban health)
- Population pushed below the $1.90 a day poverty line by household health expenditures (%) (Universal health coverage)
- Population pushed below the $3.10 a day poverty line by household health expenditures (%) (Universal health coverage)
- Population using safely managed drinking-water services (%) (Global strategy for women's, children's and adolescents' health)
- Population using at least basic drinking-water services (%) (Global strategy for women's, children's and adolescents' health)
- Population using safely managed sanitation services (%) (Global strategy for women's, children's and adolescents' health)
- Population using solid fuels (%) (Public health and environment)
- Proportion of population with primary reliance on clean fuels and technologies (%) (Global strategy for women's, children's and adolescents' health)
- Prevalence of HIV among adults aged 15 to 49 (%) (HIV/AIDS)
- Point prevalence (%), alcohol use disorders, 15+ years (Resources for Substance Use Disorders)
- Prevalence of anaemia in pregnant women (%) (Global strategy for women's, children's and adolescents' health)
- Prevalence of anaemia in non-pregnant women (%) (Global strategy for women's, children's and adolescents' health)
- Prevalence of anaemia in women of reproductive age (%) (Global strategy for women's, children's and adolescents' health)
- Point prevalence (%), drug use disorders, 15+ years (Resources for Substance Use Disorders)
- Prevalence of obesity among adults, BMI ≥ 30 (crude estimate) (%) (Noncommunicable diseases)
- Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%) (Noncommunicable diseases)
- Prevalence of overweight among adults, BMI ≥ 25 (crude estimate) (%) (Noncommunicable diseases)
- Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%) (Noncommunicable diseases)
- Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%) (Body Mass Index (BMI))
- Prevalence of underweight among adults, BMI < 18 (age-standardized estimate) (%) (Body Mass Index (BMI))
- Prevalence of underweight among adults, BMI < 18 (crude estimate) (%) (Body Mass Index (BMI))
- Prevention activities for substance use disorders, main focus (Resources for Substance Use Disorders)
- Programmes for the prevention of substance use disorders for special populations (Resources for Substance Use Disorders)
- Previously treated cases, excluding relapse (Tuberculosis)
- Price measures (Global Information System on Alcohol and Health)
- Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities (Noncommunicable diseases)
- Procurement of medical devices carried out at the national level (Priority health technologies)
- Psychoactive substance causing entry into treatment (Resources for Substance Use Disorders)
- Pubs and bars (national legislation) (Noncommunicable diseases)
- Public transport (national legislation) (Noncommunicable diseases)
- Prevalence of condom use by adults during higher-risk sex (15-49) (%) (Sexually Transmitted Infections)
- Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%) (Sexually Transmitted Infections)
- Prevalence of current tobacco use among adolescents aged 13-15 years (Global Dementia Observatory (GDO))
- Prevalence of smoking any tobacco product among persons aged >= 15 years (Global Dementia Observatory (GDO))
- Prevalence of obesity among adults, BMI ≥ 30 (age-standardized estimate) (%) (Global Dementia Observatory (GDO))
- Prevalence of overweight among adults, BMI ≥ 25 (age-standardized estimate) (%) (Global Dementia Observatory (GDO))
- Protect from tobacco smoke (Noncommunicable diseases)
- Prevalence of (moderate or severe) stunting in children (Urban health)
- Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (age-standardized estimate) (%) (Child health)
- Prevalence of current cigarette smoking (Urban health)
- Prevalence of (moderate or severe) underweight in children (Urban health)
- Proportion of women aged 20-24 years who were married or in a union by age 15 (%) (Global strategy for women's, children's and adolescents' health)
- Proportion of women aged 20-24 years who were married or in a union by age 18 (%) (Global strategy for women's, children's and adolescents' health)
R
- Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images (Noncommunicable diseases)
- Road traffic crashes, age-standardized death rates (15+), per 100,000 population (Global Information System on Alcohol and Health)
- Response (International Health Regulations (2005) monitoring framework)
- Risk communication (International Health Regulations (2005) monitoring framework)
- Radionuclear (International Health Regulations (2005) monitoring framework)
- Reported number of people receiving antiretroviral therapy (HIV/AIDS)
- Reported number of people receiving antiretroviral therapy, month and year of report (HIV/AIDS)
- Residential long-term care beds (per 10 000 population) (Global Dementia Observatory (GDO))
- Routine monitoring of people with dementia (Global Dementia Observatory (GDO))
- Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) (Universal health coverage)
- Requirement of motorcycle helmet use to adhere to standard (Road Safety)
- Restriction and inspection of facilities (Public health and environment)
- Regular reports from national monitoring systems (Global Information System on Alcohol and Health)
- Reported currency (Noncommunicable diseases)
- Restrictions on sales promotion from owners of pubs and bars (alcohol for free) (Global Information System on Alcohol and Health)
- Reported % of seriously injured patients transported by ambulance (Road Safety)
- Representativeness of survey of adults - smokeless (Noncommunicable diseases)
- Representativeness of survey of adults (Noncommunicable diseases)
- Representativeness of youth survey (Noncommunicable diseases)
- Representativeness of survey of youth - smokeless (Noncommunicable diseases)
- Relapse cases: Pulmonary, bacteriologically confirmed (Tuberculosis)
- Relapse cases: Pulmonary, clinically diagnosed (Tuberculosis)
- Relapse cases: extrapulmonary (Tuberculosis)
- Relapse cases (pre-2013 definition) (Tuberculosis)
- Restrictions on sales promotion from producers (parties, events) (Global Information System on Alcohol and Health)
- Restaurants (national legislation) (Noncommunicable diseases)
- Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate) (Noncommunicable diseases)
- Raised fasting blood glucose (>= 7.0 mmol/L or on medication) (crude estimate) (Noncommunicable diseases)
- Raised total cholesterol (>= 5.0 mmol/L) (crude estimate) (Noncommunicable diseases)
- Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate) (Noncommunicable diseases)
- Raised total cholesterol (≥ 6.2 mmol/L) (crude estimate) (Noncommunicable diseases)
- Raised total cholesterol (≥ 6.2 mmol/L) (age-standardized estimate) (Noncommunicable diseases)
- Random breath testing (RBT) use (Global Information System on Alcohol and Health)
- Reported number of human rabies deaths (Neglected tropical diseases)
- Reported number of individuals treated for onchocerciasis (Neglected tropical diseases)
- Restrictions on alcohol use in public places (Global Information System on Alcohol and Health)
- Restrictions on product placement in films/movies (Global Information System on Alcohol and Health)
- Restrictions on product placement on cable television (Global Information System on Alcohol and Health)
- Restrictions on product placement on national television (Global Information System on Alcohol and Health)
- Restrictions on sales promotion from retailers (sales below cost) (Global Information System on Alcohol and Health)
- Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate) (Global Dementia Observatory (GDO))
- Raised fasting blood glucose (>=7.0 mmol/L or on medication)(age-standardized estimate) (Global Dementia Observatory (GDO))
- Rubella - number of reported cases (Vaccine-preventable communicable diseases)
- Restrictions on sponsorship of sporting events (Global Information System on Alcohol and Health)
- Raise taxes on tobacco (Noncommunicable diseases)
- Restrictions on sponsorship of youth events (Global Information System on Alcohol and Health)
S
- Subnational bans on tobacco advertising, promotion and sponsorship (Noncommunicable diseases)
- Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place (Noncommunicable diseases)
- Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors (Noncommunicable diseases)
- Smokeless tobacco packaging and labelling must not use descriptors depicting flavours (Noncommunicable diseases)
- Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark (Noncommunicable diseases)
- Smokeless tobacco packaging and labelling must display qualitative information on relevant constituents and emissions (Noncommunicable diseases)
- Smokeless tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas (Noncommunicable diseases)
- Smokeless tobacco packaging and labelling must not display expiry dates (Noncommunicable diseases)
- Sector for inpatient treatment of alcohol dependence (Resources for Substance Use Disorders)
- Sector for outpatient treatment of alcohol dependence (Resources for Substance Use Disorders)
- Sector for inpatient detoxification of alcohol use disorders (Resources for Substance Use Disorders)
- Sector for residential long-term rehabilitation of alcohol use disorders (Resources for Substance Use Disorders)
- Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions (Resources for Substance Use Disorders)
- Surveillance (International Health Regulations (2005) monitoring framework)
- Sponsored events (Noncommunicable diseases)
- Second-hand smoke attributable deaths (Public health and environment)
- Second-hand smoke attributable DALYs ('000) (Public health and environment)
- Second-hand smoke attributable deaths per 100'000 capita (Public health and environment)
- Second-hand smoke attributable DALYs per 100'000 capita (Public health and environment)
- Second-hand smoke attributable deaths ('000) in children under 5 years (Public health and environment)
- Second-hand smoke attributable deaths per 100'000 children under 5 years (Public health and environment)
- Second-hand smoke attributable DALYs ('000) in children under 5 years (Public health and environment)
- Second-hand smoke attributable DALYs per 100'000 children under 5 years (Public health and environment)
- Subnational smoke-free legislation authority exists (Noncommunicable diseases)
- Social workers working in mental health sector (per 100,000) (Global Dementia Observatory (GDO))
- Sector for inpatient treatment of drug dependence (Resources for Substance Use Disorders)
- Sector for outpatient treatment of drug dependence (Resources for Substance Use Disorders)
- Sector for inpatient detoxification of drug use disorders (Resources for Substance Use Disorders)
- Sector for residential long-term rehabilitation of drug use disorders (Resources for Substance Use Disorders)
- Specialized treatment services for drug use disoders and HIV/AIDS (Resources for Substance Use Disorders)
- Stunting prevalence in children aged < 3 years (%) (Health Equity Monitor)
- Stunting prevalence in children aged < 5 years (%) (Health Equity Monitor)
- Specific absorption rate (SAR) (W/kg) (Public health and environment)
- Stunting prevalence (Child malnutrition)
- Stunting numbers (in millions) (Child malnutrition)
- Stand-alone policy or plan for mental health (Mental health)
- Stand-alone mental health legislation (Mental health)
- Safety requirements (Public health and environment)
- Screening and brief interventions for substance use and substance use disorders (Resources for Substance Use Disorders)
- Seat-belt wearing rate (%) (Road Safety)
- Sectors represented in national alcohol policy (Global Information System on Alcohol and Health)
- Self-help groups for substance use disorders (Resources for Substance Use Disorders)
- Server training (Global Information System on Alcohol and Health)
- Service delivery data collection system for substance use disorders (Resources for Substance Use Disorders)
- Sex workers with active syphilis (%) (Sexually Transmitted Infections)
- Skilled health professionals density (per 10 000 population) (Health workforce)
- Sobriety checkpoints (Global Information System on Alcohol and Health)
- Social costs of alcohol use in millions US$ (Global Information System on Alcohol and Health)
- Standard drink defined (Global Information System on Alcohol and Health)
- Standard drink measures, in grams per unit (Global Information System on Alcohol and Health)
- Standards of care for health professionals (Resources for Substance Use Disorders)
- Standards of care for health professionals, human rights (Resources for Substance Use Disorders)
- Standards of care for health professionals, maintenance (Resources for Substance Use Disorders)
- Status of elimination of trachoma as a public health problem (Neglected tropical diseases)
- Status of yaws endemicity (Neglected tropical diseases)
- Status of bejel endemicity (Neglected tropical diseases)
- Status of endemicity of cutaneous leishmaniasis (Neglected tropical diseases)
- Status of endemicity of onchocerciasis (Neglected tropical diseases)
- Status of pinta endemicity (Neglected tropical diseases)
- Status of endemicity of visceral leishmaniasis (Neglected tropical diseases)
- Stillbirth rate (per 1000 total births) (Global strategy for women's, children's and adolescents' health)
- Specialized treatment services for substance use disorders and TB (Resources for Substance Use Disorders)
- Substance use policy at the national level (Resources for Substance Use Disorders)
- Substance use policy at the national level, level of integration (Resources for Substance Use Disorders)
- Sector for substitution maintenance therapy of opioid dependence (Resources for Substance Use Disorders)
- Supervision requirements for buprenorphine administration (Resources for Substance Use Disorders)
- Supervision requirements for buprenorphine/naloxone administration (Resources for Substance Use Disorders)
- Supervision requirements for methadone administration (Resources for Substance Use Disorders)
T
- Tobacco companies funding or making in-kind contributions to smoking prevention media campaigns (Noncommunicable diseases)
- The quit line number must appear on cigarette packaging or labelling (Noncommunicable diseases)
- The quit line number must appear on other smoked tobacco packaging or labelling (Noncommunicable diseases)
- The quit line number must appear on smokeless tobacco packaging or labelling (Noncommunicable diseases)
- Total population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (%) (Universal health coverage)
- Total population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (millions) (Universal health coverage)
- Total population with household expenditures on health greater than 25% of total household expenditure or income ( SDG indicator 3.8.2) (%) (Universal health coverage)
- Total population with household expenditures on health greater than 25% of total household expenditure or income ( SDG indicator 3.8.2) (millions) (Universal health coverage)
- Type of national cervical cancer screening program (Universal health coverage)
- Tobacco excises increased over the survey period (Noncommunicable diseases)
- TB patients with known HIV status (%) (Tuberculosis)
- Tested TB patients HIV-positive (%) (Tuberculosis)
- Total density per 100 000 population: Hospitals (Global Dementia Observatory (GDO))
- Total dementia hospital admissions (per 100,000) (Global Dementia Observatory (GDO))
- Targets for monitoring implementation of dementia national plan (Global Dementia Observatory (GDO))
- Total expenditure on dementia research (local currency, self-report) (Global Dementia Observatory (GDO))
- Total expenditure on dementia basic research (local currency, self-report) (Global Dementia Observatory (GDO))
- Total expenditure on dementia clinical/translational research (local currency, self-report) (Global Dementia Observatory (GDO))
- Total expenditure on dementia implementation research (local currency, self-report) (Global Dementia Observatory (GDO))
- Total fertility rate (per woman) (Health Equity Monitor)
- Total density per 100 000 population: Health posts (Priority health technologies)
- Total density per 100 000 population: Health centres (Priority health technologies)
- Total density per 100 000 population: District/rural hospitals (Priority health technologies)
- Total density per 100 000 population: Provincial hospitals (Priority health technologies)
- Total density per 100 000 population: Specialized hospitals (Priority health technologies)
- The sale of all smokeless tobacco products is completely banned (Noncommunicable diseases)
- Total workforce in mental health sector (per 100,000) (Mental health)
- Tx - person-years lived above age x (Mortality and global health estimates)
- Types of lists recommending health technology for high burden diseases (Priority health technologies)
- Total density per million population: Magnetic Resonance Imaging (Priority health technologies)
- Total density per million population: Computed tomography units (Priority health technologies)
- Total density per million population: Positron Emission tomography (Priority health technologies)
- Total density per million population: Gamma camera or Nuclear medicine (Priority health technologies)
- Total density per million population: Linear Accelerator (Priority health technologies)
- Total density per million population: Telecobalt Unit (Priority health technologies)
- Total density per million population: Radiotherapy units (Priority health technologies)
- Total density per million females aged from 50 to 69 years old: Mammography units (Priority health technologies)
- Types of AST standards followed by countries (Antimicrobial resistance (AMR))
- Training requirements (Public health and environment)
- Treatment history unknown (Tuberculosis)
- Type of nomenclature system (Priority health technologies)
- Total population pushed below the $1.90 a day poverty line by household health expenditures (%) (Universal health coverage)
- Total population pushed below the $1.90 a day poverty line by household health expenditures (millions) (Universal health coverage)
- Total population pushed below the $3.10 a day poverty line by household health expenditures (%) (Universal health coverage)
- Total population pushed below the $3.10 a day poverty line by household health expenditures (millions) (Universal health coverage)
- Total number of published dementia research output (Global Dementia Observatory (GDO))
- Tax structure: Excise tax proportion of price (Noncommunicable diseases)
- Tax structure: Type of excise tax applied (Noncommunicable diseases)
- Tax structure: Uniform excise tax (Noncommunicable diseases)
- Tax structure: Greater reliance on specific tax in mixed excise regime (Noncommunicable diseases)
- Tax structure: Minimum specific tax applied in ad valorem or mixed excise regime (Noncommunicable diseases)
- Tax structure: Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT) (Noncommunicable diseases)
- Tax administration: Tax stamps applied on tobacco products (Noncommunicable diseases)
- Tax administration: Bans or limits on duty free imports by travellers (Noncommunicable diseases)
- Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks) (Noncommunicable diseases)
- Testing and counselling facilities, reported number (HIV/AIDS)
- Testing and counselling facilities, estimated number per 100 000 adult population (HIV/AIDS)
- Testing and counselling facilities, reporting period (HIV/AIDS)
- Timeframe of opioid agonist treatment (Resources for Substance Use Disorders)
- Total NCD Deaths (in thousands) (Noncommunicable diseases)
- Total (recorded+unrecorded) alcohol per capita (15+) consumption (Global Information System on Alcohol and Health)
- Total tetanus - number of reported cases (Vaccine-preventable communicable diseases)
- Training in medical emergency - available for doctors (Road Safety)
- Training in medical emergency - available for nurses (Road Safety)
- Tuberculosis - new and relapse cases (Tuberculosis)
- Treatment for tobacco dependence available in hospitals (Noncommunicable diseases)
- Treatment for tobacco dependence in hospitals cost covered (Noncommunicable diseases)
- Treatment for tobacco dependence available in health clinics or other primary care facilities (Noncommunicable diseases)
- Treatment for tobacco dependence in health clinics or other primary care facilities cost covered (Noncommunicable diseases)
- Treatment for tobacco dependence available in offices of health professionals (Noncommunicable diseases)
- Treatment for tobacco dependence in offices of health professionals cost covered (Noncommunicable diseases)
- Treatment for tobacco dependence available in the community (Noncommunicable diseases)
- Treatment for tobacco dependence in the community cost covered (Noncommunicable diseases)
- Treatment for tobacco dependence available in other settings (Noncommunicable diseases)
- Treatment for tobacco dependence in other settings cost covered (Noncommunicable diseases)
- Treatment setting for substance use disorders, most common (Resources for Substance Use Disorders)
- Treatment slots for alcohol and drug use disorders, outpatient, per 10 000 (Resources for Substance Use Disorders)
- Treatment success rate: previously treated TB cases (Tuberculosis)
- Treatment success rate: HIV-positive TB cases (Tuberculosis)
- Treatment success rate for patients treated for MDR-TB (%) (Tuberculosis)
- Treatment success rate: XDR-TB cases (Tuberculosis)
- Treatment system for substance use disorders (Resources for Substance Use Disorders)
- Tuberculosis treatment coverage (Universal health coverage)
- Tuberculosis effective treatment coverage (%) (Universal health coverage)
- Treatment success rate: new TB cases (Universal health coverage)
U
- Underweight prevalence in children aged < 3 years (%) (Health Equity Monitor)
- Underweight prevalence in children aged < 5 years (%) (Health Equity Monitor)
- Under-five mortality rate (deaths per 1000 live births) (Health Equity Monitor)
- UV radiation (Public health and environment)
- Underweight prevalence (Child malnutrition)
- Underweight numbers (in millions) (Child malnutrition)
- Unit in the Ministry of Health responsible for the management of medical devices (Priority health technologies)
- UHC index of essential service coverage (%) (Universal health coverage)
- UV radiation attributable deaths (Public health and environment)
- UV radiation attributable DALYs ('000) (Public health and environment)
- UV radiation attributable deaths per 100'000 capita (Public health and environment)
- UV radiation attributable DALYs per 100'000 capita (Public health and environment)
- Use of nomenclature system (Priority health technologies)
- Universities (national legislation) (Noncommunicable diseases)
- Under-five mortality per 1 000 live births (Urban health)
- Under-five mortality rate (probability of dying by age 5 per 1000 live births) (Global strategy for women's, children's and adolescents' health)
V
- Varenicline - legally sold (Noncommunicable diseases)
- Varenicline - place available (Noncommunicable diseases)
- Varenicline - cost covered (Noncommunicable diseases)
- Value-added tax (VAT) on alcohol (%) (Global Information System on Alcohol and Health)
- Vehicle standards (Road Safety)
W
- Wasting prevalence in children aged < 3 years (%) (Health Equity Monitor)
- Wasting prevalence in children aged < 5 years (%) (Health Equity Monitor)
- Wasting prevalence (Child malnutrition)
- Wasting numbers (in thousands) (Child malnutrition)
- Warn about the dangers of tobacco (Noncommunicable diseases)
- Women accessing antenatal care (ANC) services who were tested for syphilis (%) (Global strategy for women's, children's and adolescents' health)
- Women age 15-49 years who received a health check within 2 days after delivery of their most recent live birth in the last 2 years (%) (Global strategy for women's, children's and adolescents' health)
- Workplace representatives nationally involved to prevent and address alcohol-related harm (Global Information System on Alcohol and Health)
Y
- Year of national implementation of regulation (Public health and environment)
- Year of survey of adults - smokeless (Noncommunicable diseases)
- Year of survey of adults (Noncommunicable diseases)
- Year of survey of youth (Noncommunicable diseases)
- Youth survey age range (Noncommunicable diseases)
- Youth indicator 1 definition (Noncommunicable diseases)
- Youth indicator 1 rate (Noncommunicable diseases)
- Youth indicator 2 definition (Noncommunicable diseases)
- Youth indicator 2 rate (Noncommunicable diseases)
- Year of survey of youth - smokeless (Noncommunicable diseases)
- Youth survey age range - smokeless (Noncommunicable diseases)
- Youth smokeless tobacco use indicator definition (Noncommunicable diseases)
- Youth smokeless tobacco use indicator rate (Noncommunicable diseases)
- Youth violence: Extent of implementation of life-skills and social development programmes (Violence prevention)
- Yellow fever - number of reported cases (Vaccine-preventable communicable diseases)
Z
1
- 13-15-years old any alcoholic beverage consumed in past 30 days, (%) (Global Information System on Alcohol and Health)
- 13-15-years old first drink before age 14, (%) (Global Information System on Alcohol and Health)
- 15-years old any alcoholic beverage consumed in past 12 months, (%) (Global Information System on Alcohol and Health)
- 15-years old any alcoholic beverage consumed in past 30 days, (%) (Global Information System on Alcohol and Health)
- 15-years old first drink at 13 years or younger, (%) (Global Information System on Alcohol and Health)
- 15-years old, any alcoholic beverage consumed at least once a week, (%) (Global Information System on Alcohol and Health)
- 15-19 years old abstainers, lifetime (%) (Global Information System on Alcohol and Health)
- 15-19 years old former drinkers (%) (Global Information System on Alcohol and Health)
- 15-19 years old heavy episodic drinkers (drinkers only), % (Global Information System on Alcohol and Health)
- 15-19 years old heavy episodic drinkers (population), % with 95%CI (Global Information System on Alcohol and Health)
- 15-19 years old total alcohol consumption in litres of pure alcohol (Global Information System on Alcohol and Health)
- 15-19 years old, current drinkers (%) (Global Information System on Alcohol and Health)
